ID

DB08952||

名称

Indenolol

描述

Indenolol is a drug of the beta-adrenergic blocker class.

cas号

60607-68-3

唯一标识码

3MZM7RWW00

状态

solid

组

withdrawn,

指示

药效学

作用机制

毒性

代谢

吸收

半衰期

分类

description:This compound belongs to the class of organic compounds known as indenes and isoindenes. These are compounds containing an indene moiety(which consists of a cyclopentadiene fused to a benzene ring), or a isoindene moiety (which consists of a cyclopentadiene fused to cyclohexadiene ring).
direct-parent:Indenes and isoindenes
kingdom:Organic compounds
superclass:Benzenoids
class:Indenes and isoindenes
subclass:
alternative-parent:1,2-aminoalcohols
alternative-parent:Alkyl aryl ethers
alternative-parent:Dialkylamines
alternative-parent:Hydrocarbon derivatives
alternative-parent:Organopnictogen compounds
alternative-parent:Secondary alcohols
substituent:1,2-aminoalcohol
substituent:Alcohol
substituent:Alkyl aryl ether
substituent:Amine
substituent:Aromatic homopolycyclic compound
substituent:Ether
substituent:Hydrocarbon derivative
substituent:Indene
substituent:Organic nitrogen compound
substituent:Organic oxygen compound
substituent:Organonitrogen compound
substituent:Organooxygen compound
substituent:Organopnictogen compound
substituent:Secondary alcohol
substituent:Secondary aliphatic amine
substituent:Secondary amine

消除途径

种类

Adrenergic Agents
D018663
Adrenergic Antagonists
D018674
Adrenergic beta-Antagonists
D000319
Agents causing hyperkalemia

Alcohols
D000438
Amines
D000588
Amino Alcohols
D000605
Antiarrhythmic agents
D000889
Antihypertensive Agents
D000959
Bradycardia-Causing Agents

Cardiovascular Agents
D002317
Cytochrome P-450 CYP2D6 Substrates

Cytochrome P-450 Substrates

Moderate Risk QTc-Prolonging Agents

Neurotransmitter Agents
D018377
Potential QTc-Prolonging Agents

Propanols
D020005
QTc Prolonging Agents

Vasodilating Agents
D014665

盐类

蛋白质结合

清除

同义词

国际品牌

配送量

产品

混合物

包装者

生产者

价格

受影响的生物体

剂量

atc代码

fda标签

化学品安全技术说明书

专利

食物相互作用

药物相互作用

DB09063
Indenolol may increase the bradycardic activities of Ceritinib.
DB09083
Indenolol may increase the bradycardic activities of Ivabradine.
DB08877
Ruxolitinib may increase the bradycardic activities of Indenolol.
DB00346
Alfuzosin may increase the hypotensive activities of Indenolol.
DB01143
Indenolol may increase the hypotensive activities of Amifostine.
DB01119
Diazoxide may increase the hypotensive activities of Indenolol.
DB00422
Methylphenidate may decrease the antihypertensive activities of Indenolol.
DB06701
Dexmethylphenidate may decrease the antihypertensive activities of Indenolol.
DB08935
Indenolol may increase the hypotensive activities of Obinutuzumab.
DB00806
Pentoxifylline may increase the hypotensive activities of Indenolol.
DB00073
Indenolol may increase the hypotensive activities of Rituximab.
DB00035
Desmopressin may decrease the antihypertensive activities of Indenolol.
DB00315
Zolmitriptan may decrease the antihypertensive activities of Indenolol.
DB00561
Doxapram may decrease the antihypertensive activities of Indenolol.
DB00669
Sumatriptan may decrease the antihypertensive activities of Indenolol.
DB00830
Phenmetrazine may decrease the antihypertensive activities of Indenolol.
DB00952
Naratriptan may decrease the antihypertensive activities of Indenolol.
DB00953
Rizatriptan may decrease the antihypertensive activities of Indenolol.
DB00988
Dopamine may decrease the antihypertensive activities of Indenolol.
DB00998
Frovatriptan may decrease the antihypertensive activities of Indenolol.
DB01126
Dutasteride may decrease the antihypertensive activities of Indenolol.
DB01216
Finasteride may decrease the antihypertensive activities of Indenolol.
DB01392
Yohimbine may decrease the antihypertensive activities of Indenolol.
DB02032
Epicaptopril may decrease the antihypertensive activities of Indenolol.
DB04581
1-benzylimidazole may decrease the antihypertensive activities of Indenolol.
DB04836
Amineptine may decrease the antihypertensive activities of Indenolol.
DB04908
Flibanserin may decrease the antihypertensive activities of Indenolol.
DB05562
Naluzotan may decrease the antihypertensive activities of Indenolol.
DB06690
Nitrous oxide may decrease the antihypertensive activities of Indenolol.
DB08810
Cinitapride may decrease the antihypertensive activities of Indenolol.
DB08841
Tyramine may decrease the antihypertensive activities of Indenolol.
DB08954
Ifenprodil may decrease the antihypertensive activities of Indenolol.
DB08996
Dimetacrine may decrease the antihypertensive activities of Indenolol.
DB09205
Moxisylyte may decrease the antihypertensive activities of Indenolol.
DB09289
Tianeptine may decrease the antihypertensive activities of Indenolol.
DB09307
Oxaprotiline may decrease the antihypertensive activities of Indenolol.
DB11481
Atipamezole may decrease the antihypertensive activities of Indenolol.
DB11755
Tetrahydrocannabivarin may decrease the antihypertensive activities of Indenolol.
DB12361
Piclozotan may decrease the antihypertensive activities of Indenolol.
DB12371
Siponimod may decrease the antihypertensive activities of Indenolol.
DB12551
Idazoxan may decrease the antihypertensive activities of Indenolol.
DB13064
Tramazoline may decrease the antihypertensive activities of Indenolol.
DB13114
Amitriptylinoxide may decrease the antihypertensive activities of Indenolol.
DB13225
Dibenzepin may decrease the antihypertensive activities of Indenolol.
DB13246
Quinupramine may decrease the antihypertensive activities of Indenolol.
DB13323
Trichloroethylene may decrease the antihypertensive activities of Indenolol.
DB13341
Fenozolone may decrease the antihypertensive activities of Indenolol.
DB13384
Melitracen may decrease the antihypertensive activities of Indenolol.
DB13411
Lofepramine may decrease the antihypertensive activities of Indenolol.
DB13453
Xenon may decrease the antihypertensive activities of Indenolol.
DB13496
Iprindole may decrease the antihypertensive activities of Indenolol.
DB13510
Buflomedil may decrease the antihypertensive activities of Indenolol.
DB13598
Diethyl ether may decrease the antihypertensive activities of Indenolol.
DB13782
Imipramine oxide may decrease the antihypertensive activities of Indenolol.
DB13852
Mefenorex may decrease the antihypertensive activities of Indenolol.
DB14010
5-methoxy-N,N-dimethyltryptamine may decrease the antihypertensive activities of Indenolol.
DB14231
Quinoline Yellow WS may decrease the antihypertensive activities of Indenolol.
DB14754
Solriamfetol may decrease the antihypertensive activities of Indenolol.
DB00708
Sufentanil may decrease the antihypertensive activities of Indenolol.
DB00899
Remifentanil may decrease the antihypertensive activities of Indenolol.
DB01159
Halothane may decrease the antihypertensive activities of Indenolol.
DB12930
Opipramol may decrease the antihypertensive activities of Indenolol.
DB15685
Selpercatinib may decrease the antihypertensive activities of Indenolol.
DB15965
Naxitamab may decrease the antihypertensive activities of Indenolol.
DB01118
The therapeutic efficacy of Indenolol can be increased when used in combination with Amiodarone.
DB00297
The serum concentration of Bupivacaine can be increased when it is combined with Indenolol.
DB00975
Dipyridamole may increase the bradycardic activities of Indenolol.
DB00280
Disopyramide may increase the bradycardic activities of Indenolol.
DB04855
Dronedarone may increase the bradycardic activities of Indenolol.
DB08868
Indenolol may increase the bradycardic activities of Fingolimod.
DB08976
The risk or severity of adverse effects can be increased when Indenolol is combined with Floctafenine.
DB00961
The serum concentration of Mepivacaine can be increased when it is combined with Indenolol.
DB06709
Indenolol may increase the bronchoconstrictory activities of Methacholine.
DB00211
The therapeutic efficacy of Midodrine can be decreased when used in combination with Indenolol.
DB01115
The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Indenolol.
DB01182
The risk or severity of adverse effects can be increased when Propafenone is combined with Indenolol.
DB08896
Regorafenib may increase the bradycardic activities of Indenolol.
DB00206
Reserpine may increase the hypotensive activities of Indenolol.
DB01089
Deserpidine may increase the hypotensive activities of Indenolol.
DB01170
Guanethidine may increase the hypotensive activities of Indenolol.
DB00989
Indenolol may increase the bradycardic activities of Rivastigmine.
DB09282
Molsidomine may increase the hypotensive activities of Indenolol.
DB11564
Indenolol may increase the hypoglycemic activities of Insulin argine.
DB00212
Remikiren may increase the hypotensive activities of Indenolol.
DB00226
Guanadrel may increase the hypotensive activities of Indenolol.
DB00287
Travoprost may increase the hypotensive activities of Indenolol.
DB00559
Bosentan may increase the hypotensive activities of Indenolol.
DB00616
Candoxatril may increase the hypotensive activities of Indenolol.
DB00765
Metyrosine may increase the hypotensive activities of Indenolol.
DB00785
Cryptenamine may increase the hypotensive activities of Indenolol.
DB00869
Dorzolamide may increase the hypotensive activities of Indenolol.
DB00905
Bimatoprost may increase the hypotensive activities of Indenolol.
DB01090
Pentolinium may increase the hypotensive activities of Indenolol.
DB01116
Trimethaphan may increase the hypotensive activities of Indenolol.
DB04831
Tienilic acid may increase the hypotensive activities of Indenolol.
DB04840
Debrisoquine may increase the hypotensive activities of Indenolol.
DB06268
Sitaxentan may increase the hypotensive activities of Indenolol.
DB06403
Ambrisentan may increase the hypotensive activities of Indenolol.
DB06445
Diethylnorspermine may increase the hypotensive activities of Indenolol.
DB06762
Pinacidil may increase the hypotensive activities of Indenolol.
DB06826
Unoprostone may increase the hypotensive activities of Indenolol.
DB07767
Ferulic acid may increase the hypotensive activities of Indenolol.
DB08932
Macitentan may increase the hypotensive activities of Indenolol.
DB08960
Indenolol may increase the hypotensive activities of Hexamethonium.
DB09363
Indenolol may increase the hypotensive activities of Rauwolfia serpentina root.
DB11362
Indenolol may increase the hypotensive activities of Selexipag.
DB11720
Indenolol may increase the hypotensive activities of Angiotensin 1-7.
DB12054
Indenolol may increase the hypotensive activities of BQ-123.
DB12465
Indenolol may increase the hypotensive activities of Ketanserin.
DB12945
Indenolol may increase the hypotensive activities of Dihydralazine.
DB13211
Indenolol may increase the hypotensive activities of Guanoxan.
DB13374
Indenolol may increase the hypotensive activities of Vincamine.
DB13400
Indenolol may increase the hypotensive activities of Linsidomine.
DB13410
Indenolol may increase the hypotensive activities of Guanoxabenz.
DB13429
Indenolol may increase the hypotensive activities of Tolonidine.
DB13435
Indenolol may increase the hypotensive activities of Endralazine.
DB13452
Indenolol may increase the hypotensive activities of Cadralazine.
DB13575
Indenolol may increase the hypotensive activities of Bietaserpine.
DB13604
Indenolol may increase the hypotensive activities of Guanazodine.
DB13631
Indenolol may increase the hypotensive activities of Methoserpidine.
DB13779
Indenolol may increase the hypotensive activities of Guanoclor.
DB13801
Indenolol may increase the hypotensive activities of Muzolimine.
DB13803
Indenolol may increase the hypotensive activities of Xipamide.
DB14094
Indenolol may increase the hypotensive activities of Tocopherylquinone.
DB00214
Torasemide may increase the hypotensive activities of Indenolol.
DB00310
Chlorthalidone may increase the hypotensive activities of Indenolol.
DB00325
Nitroprusside may increase the hypotensive activities of Indenolol.
DB00350
Minoxidil may increase the hypotensive activities of Indenolol.
DB00524
Metolazone may increase the hypotensive activities of Indenolol.
DB00657
Mecamylamine may increase the hypotensive activities of Indenolol.
DB00695
Furosemide may increase the hypotensive activities of Indenolol.
DB00727
Nitroglycerin may increase the hypotensive activities of Indenolol.
DB00800
Fenoldopam may increase the hypotensive activities of Indenolol.
DB01275
Hydralazine may increase the hypotensive activities of Indenolol.
DB08931
Riociguat may increase the hypotensive activities of Indenolol.
DB00178
Ramipril may increase the hypotensive activities of Indenolol.
DB00790
Perindopril may increase the hypotensive activities of Indenolol.
DB09237
Indenolol may increase the hypotensive activities of Levamlodipine.
DB00484
Brimonidine may increase the antihypertensive activities of Indenolol.
DB00184
The risk or severity of adverse effects can be increased when Indenolol is combined with Nicotine.
DB00185
The risk or severity of adverse effects can be increased when Indenolol is combined with Cevimeline.
DB00411
The risk or severity of adverse effects can be increased when Indenolol is combined with Carbamoylcholine.
DB01019
The risk or severity of adverse effects can be increased when Indenolol is combined with Bethanechol.
DB01085
The risk or severity of adverse effects can be increased when Indenolol is combined with Pilocarpine.
DB01273
The risk or severity of adverse effects can be increased when Indenolol is combined with Varenicline.
DB03128
The risk or severity of adverse effects can be increased when Indenolol is combined with Acetylcholine.
DB04365
The risk or severity of adverse effects can be increased when Indenolol is combined with Arecoline.
DB05137
The risk or severity of adverse effects can be increased when Indenolol is combined with Lobeline.
DB05152
The risk or severity of adverse effects can be increased when Indenolol is combined with NGX267.
DB05708
The risk or severity of adverse effects can be increased when Indenolol is combined with GTS-21.
DB07720
The risk or severity of adverse effects can be increased when Indenolol is combined with Epibatidine.
DB15357
The risk or severity of adverse effects can be increased when Indenolol is combined with Xanomeline.
DB00372
The serum concentration of Indenolol can be increased when it is combined with Thiethylperazine.
DB00420
The serum concentration of Indenolol can be increased when it is combined with Promazine.
DB00433
The serum concentration of Indenolol can be increased when it is combined with Prochlorperazine.
DB00508
The serum concentration of Indenolol can be increased when it is combined with Triflupromazine.
DB00623
The serum concentration of Indenolol can be increased when it is combined with Fluphenazine.
DB00831
The serum concentration of Indenolol can be increased when it is combined with Trifluoperazine.
DB00850
The serum concentration of Indenolol can be increased when it is combined with Perphenazine.
DB00933
The serum concentration of Indenolol can be increased when it is combined with Mesoridazine.
DB01063
The serum concentration of Indenolol can be increased when it is combined with Acetophenazine.
DB01069
The serum concentration of Indenolol can be increased when it is combined with Promethazine.
DB01246
The serum concentration of Indenolol can be increased when it is combined with Alimemazine.
DB01608
The serum concentration of Indenolol can be increased when it is combined with Periciazine.
DB01614
The serum concentration of Indenolol can be increased when it is combined with Acepromazine.
DB01615
The serum concentration of Indenolol can be increased when it is combined with Aceprometazine.
DB01621
The serum concentration of Indenolol can be increased when it is combined with Pipotiazine.
DB01622
The serum concentration of Indenolol can be increased when it is combined with Thioproperazine.
DB05687
The serum concentration of Indenolol can be increased when it is combined with BL-1020.
DB09000
The serum concentration of Indenolol can be increased when it is combined with Cyamemazine.
DB09241
The serum concentration of Indenolol can be increased when it is combined with Methylene blue.
DB11540
The serum concentration of Indenolol can be increased when it is combined with Propiopromazine.
DB12710
The serum concentration of Indenolol can be increased when it is combined with Perazine.
DB13213
The serum concentration of Indenolol can be increased when it is combined with Butaperazine.
DB13382
The serum concentration of Indenolol can be increased when it is combined with Chlorproethazine.
DB13420
The serum concentration of Indenolol can be increased when it is combined with Thiazinam.
DB13784
The serum concentration of Indenolol can be increased when it is combined with Dixyrazine.
DB14651
The serum concentration of Indenolol can be increased when it is combined with Perphenazine enanthate.
DB01092
Indenolol may increase the bradycardic activities of Ouabain.
DB12843
Indenolol may increase the bradycardic activities of Oleandrin.
DB13307
Indenolol may increase the bradycardic activities of Proscillaridin.
DB13467
Indenolol may increase the bradycardic activities of Lanatoside C.
DB13537
Indenolol may increase the bradycardic activities of Gitoformate.
DB13756
Indenolol may increase the bradycardic activities of Peruvoside.
DB00281
The serum concentration of Lidocaine can be increased when it is combined with Indenolol.
DB00159
Icosapent may decrease the antihypertensive activities of Indenolol.
DB00244
Mesalazine may decrease the antihypertensive activities of Indenolol.
DB00328
Indomethacin may decrease the antihypertensive activities of Indenolol.
DB00461
Nabumetone may decrease the antihypertensive activities of Indenolol.
DB00465
Ketorolac may decrease the antihypertensive activities of Indenolol.
DB00469
Tenoxicam may decrease the antihypertensive activities of Indenolol.
DB00482
Celecoxib may decrease the antihypertensive activities of Indenolol.
DB00500
Tolmetin may decrease the antihypertensive activities of Indenolol.
DB00533
Rofecoxib may decrease the antihypertensive activities of Indenolol.
DB00554
Piroxicam may decrease the antihypertensive activities of Indenolol.
DB00573
Fenoprofen may decrease the antihypertensive activities of Indenolol.
DB00580
Valdecoxib may decrease the antihypertensive activities of Indenolol.
DB00586
Diclofenac may decrease the antihypertensive activities of Indenolol.
DB00605
Sulindac may decrease the antihypertensive activities of Indenolol.
DB00712
Flurbiprofen may decrease the antihypertensive activities of Indenolol.
DB00749
Etodolac may decrease the antihypertensive activities of Indenolol.
DB00784
Mefenamic acid may decrease the antihypertensive activities of Indenolol.
DB00788
Naproxen may decrease the antihypertensive activities of Indenolol.
DB00795
Sulfasalazine may decrease the antihypertensive activities of Indenolol.
DB00812
Phenylbutazone may decrease the antihypertensive activities of Indenolol.
DB00814
Meloxicam may decrease the antihypertensive activities of Indenolol.
DB00821
Carprofen may decrease the antihypertensive activities of Indenolol.
DB00861
Diflunisal may decrease the antihypertensive activities of Indenolol.
DB00936
Salicylic acid may decrease the antihypertensive activities of Indenolol.
DB00939
Meclofenamic acid may decrease the antihypertensive activities of Indenolol.
DB00945
Acetylsalicylic acid may decrease the antihypertensive activities of Indenolol.
DB00991
Oxaprozin may decrease the antihypertensive activities of Indenolol.
DB01009
Ketoprofen may decrease the antihypertensive activities of Indenolol.
DB01014
Balsalazide may decrease the antihypertensive activities of Indenolol.
DB01050
Ibuprofen may decrease the antihypertensive activities of Indenolol.
DB01250
Olsalazine may decrease the antihypertensive activities of Indenolol.
DB01283
Lumiracoxib may decrease the antihypertensive activities of Indenolol.
DB01397
Magnesium salicylate may decrease the antihypertensive activities of Indenolol.
DB01399
Salsalate may decrease the antihypertensive activities of Indenolol.
DB01401
Choline magnesium trisalicylate may decrease the antihypertensive activities of Indenolol.
DB01419
Antrafenine may decrease the antihypertensive activities of Indenolol.
DB01424
Aminophenazone may decrease the antihypertensive activities of Indenolol.
DB01435
Antipyrine may decrease the antihypertensive activities of Indenolol.
DB01600
Tiaprofenic acid may decrease the antihypertensive activities of Indenolol.
DB01628
Etoricoxib may decrease the antihypertensive activities of Indenolol.
DB02224
Taxifolin may decrease the antihypertensive activities of Indenolol.
DB03585
Oxyphenbutazone may decrease the antihypertensive activities of Indenolol.
DB04725
Licofelone may decrease the antihypertensive activities of Indenolol.
DB04743
Nimesulide may decrease the antihypertensive activities of Indenolol.
DB04812
Benoxaprofen may decrease the antihypertensive activities of Indenolol.
DB04817
Metamizole may decrease the antihypertensive activities of Indenolol.
DB04828
Zomepirac may decrease the antihypertensive activities of Indenolol.
DB05095
Cimicoxib may decrease the antihypertensive activities of Indenolol.
DB06725
Lornoxicam may decrease the antihypertensive activities of Indenolol.
DB06736
Aceclofenac may decrease the antihypertensive activities of Indenolol.
DB06737
Zaltoprofen may decrease the antihypertensive activities of Indenolol.
DB07402
Azapropazone may decrease the antihypertensive activities of Indenolol.
DB08439
Parecoxib may decrease the antihypertensive activities of Indenolol.
DB08797
Salicylamide may decrease the antihypertensive activities of Indenolol.
DB08940
Kebuzone may decrease the antihypertensive activities of Indenolol.
DB08942
Isoxicam may decrease the antihypertensive activities of Indenolol.
DB08951
Indoprofen may decrease the antihypertensive activities of Indenolol.
DB08955
Ibuproxam may decrease the antihypertensive activities of Indenolol.
DB08981
Fenbufen may decrease the antihypertensive activities of Indenolol.
DB08984
Etofenamate may decrease the antihypertensive activities of Indenolol.
DB08991
Epirizole may decrease the antihypertensive activities of Indenolol.
DB09084
Benzydamine may decrease the antihypertensive activities of Indenolol.
DB09213
Dexibuprofen may decrease the antihypertensive activities of Indenolol.
DB09214
Dexketoprofen may decrease the antihypertensive activities of Indenolol.
DB09215
Droxicam may decrease the antihypertensive activities of Indenolol.
DB09216
Tolfenamic acid may decrease the antihypertensive activities of Indenolol.
DB09217
Firocoxib may decrease the antihypertensive activities of Indenolol.
DB09218
Clonixin may decrease the antihypertensive activities of Indenolol.
DB09285
Morniflumate may decrease the antihypertensive activities of Indenolol.
DB09288
Propacetamol may decrease the antihypertensive activities of Indenolol.
DB09295
Talniflumate may decrease the antihypertensive activities of Indenolol.
DB11455
Robenacoxib may decrease the antihypertensive activities of Indenolol.
DB11466
Tepoxalin may decrease the antihypertensive activities of Indenolol.
DB11518
Flunixin may decrease the antihypertensive activities of Indenolol.
DB12399
Polmacoxib may decrease the antihypertensive activities of Indenolol.
DB12445
Nitroaspirin may decrease the antihypertensive activities of Indenolol.
DB12545
Indobufen may decrease the antihypertensive activities of Indenolol.
DB12610
Ebselen may decrease the antihypertensive activities of Indenolol.
DB13001
Tinoridine may decrease the antihypertensive activities of Indenolol.
DB13167
Alclofenac may decrease the antihypertensive activities of Indenolol.
DB13217
Fentiazac may decrease the antihypertensive activities of Indenolol.
DB13232
Suxibuzone may decrease the antihypertensive activities of Indenolol.
DB13286
Bumadizone may decrease the antihypertensive activities of Indenolol.
DB13314
Alminoprofen may decrease the antihypertensive activities of Indenolol.
DB13371
Difenpiramide may decrease the antihypertensive activities of Indenolol.
DB13407
Nifenazone may decrease the antihypertensive activities of Indenolol.
DB13432
Lonazolac may decrease the antihypertensive activities of Indenolol.
DB13481
Tenidap may decrease the antihypertensive activities of Indenolol.
DB13524
Propyphenazone may decrease the antihypertensive activities of Indenolol.
DB13527
Proglumetacin may decrease the antihypertensive activities of Indenolol.
DB13538
Guacetisal may decrease the antihypertensive activities of Indenolol.
DB13544
Ethenzamide may decrease the antihypertensive activities of Indenolol.
DB13612
Carbaspirin calcium may decrease the antihypertensive activities of Indenolol.
DB13629
Mofebutazone may decrease the antihypertensive activities of Indenolol.
DB13649
Proquazone may decrease the antihypertensive activities of Indenolol.
DB13657
Benorilate may decrease the antihypertensive activities of Indenolol.
DB13722
Pirprofen may decrease the antihypertensive activities of Indenolol.
DB13783
Acemetacin may decrease the antihypertensive activities of Indenolol.
DB13860
Imidazole salicylate may decrease the antihypertensive activities of Indenolol.
DB14059
SC-236 may decrease the antihypertensive activities of Indenolol.
DB14060
NS-398 may decrease the antihypertensive activities of Indenolol.
DB14938
Flurbiprofen axetil may decrease the antihypertensive activities of Indenolol.
DB09212
Loxoprofen may decrease the antihypertensive activities of Indenolol.
DB00203
Sildenafil may increase the antihypertensive activities of Indenolol.
DB00235
Milrinone may increase the antihypertensive activities of Indenolol.
DB00820
Tadalafil may increase the antihypertensive activities of Indenolol.
DB05266
Ibudilast may increase the antihypertensive activities of Indenolol.
DB06237
Avanafil may increase the antihypertensive activities of Indenolol.
DB06267
Udenafil may increase the antihypertensive activities of Indenolol.
DB11792
Mirodenafil may increase the antihypertensive activities of Indenolol.
DB12010
Fostamatinib may increase the antihypertensive activities of Indenolol.
DB00247
Indenolol may increase the vasoconstricting activities of Methysergide.
DB00248
Indenolol may increase the vasoconstricting activities of Cabergoline.
DB00320
Indenolol may increase the vasoconstricting activities of Dihydroergotamine.
DB00353
Indenolol may increase the vasoconstricting activities of Methylergometrine.
DB00589
Indenolol may increase the vasoconstricting activities of Lisuride.
DB00696
Indenolol may increase the vasoconstricting activities of Ergotamine.
DB00699
Indenolol may increase the vasoconstricting activities of Nicergoline.
DB01049
Indenolol may increase the vasoconstricting activities of Ergoloid mesylate.
DB04829
Indenolol may increase the vasoconstricting activities of Lysergic acid diethylamide.
DB11273
Indenolol may increase the vasoconstricting activities of Dihydroergocornine.
DB13345
Indenolol may increase the vasoconstricting activities of Dihydroergocristine.
DB13385
Indenolol may increase the vasoconstricting activities of Dihydroergocryptine.
DB13399
Indenolol may increase the vasoconstricting activities of Terguride.
DB13520
Indenolol may increase the vasoconstricting activities of Metergoline.
DB01105
The serum concentration of Indenolol can be increased when it is combined with Sibutramine.
DB01149
The serum concentration of Indenolol can be increased when it is combined with Nefazodone.
DB04832
The serum concentration of Indenolol can be increased when it is combined with Zimelidine.
DB04884
The serum concentration of Indenolol can be increased when it is combined with Dapoxetine.
DB04896
The serum concentration of Indenolol can be increased when it is combined with Milnacipran.
DB06700
The serum concentration of Indenolol can be increased when it is combined with Desvenlafaxine.
DB06731
The serum concentration of Indenolol can be increased when it is combined with Seproxetine.
DB08918
The serum concentration of Indenolol can be increased when it is combined with Levomilnacipran.
DB08953
The serum concentration of Indenolol can be increased when it is combined with Indalpine.
DB13233
The serum concentration of Indenolol can be increased when it is combined with Alaproclate.
DB01104
The serum concentration of Indenolol can be increased when it is combined with Sertraline.
DB00201
The risk or severity of adverse effects can be increased when Indenolol is combined with Caffeine.
DB00651
The risk or severity of adverse effects can be increased when Indenolol is combined with Dyphylline.
DB01033
The risk or severity of adverse effects can be increased when Indenolol is combined with Mercaptopurine.
DB01223
The risk or severity of adverse effects can be increased when Indenolol is combined with Aminophylline.
DB01303
The risk or severity of adverse effects can be increased when Indenolol is combined with Oxtriphylline.
DB01412
The risk or severity of adverse effects can be increased when Indenolol is combined with Theobromine.
DB01482
The risk or severity of adverse effects can be increased when Indenolol is combined with Fenethylline.
DB01667
The risk or severity of adverse effects can be increased when Indenolol is combined with 8-azaguanine.
DB01978
The risk or severity of adverse effects can be increased when Indenolol is combined with 7,9-Dimethylguanine.
DB02134
The risk or severity of adverse effects can be increased when Indenolol is combined with Xanthine.
DB02245
The risk or severity of adverse effects can be increased when Indenolol is combined with 7-Deazaguanine.
DB02377
The risk or severity of adverse effects can be increased when Indenolol is combined with Guanine.
DB02489
The risk or severity of adverse effects can be increased when Indenolol is combined with 9-Methylguanine.
DB02568
The risk or severity of adverse effects can be increased when Indenolol is combined with Peldesine.
DB04076
The risk or severity of adverse effects can be increased when Indenolol is combined with Hypoxanthine.
DB04356
The risk or severity of adverse effects can be increased when Indenolol is combined with 9-Deazaguanine.
DB06479
The risk or severity of adverse effects can be increased when Indenolol is combined with Propentofylline.
DB06575
The risk or severity of adverse effects can be increased when Indenolol is combined with Valomaciclovir.
DB07954
The risk or severity of adverse effects can be increased when Indenolol is combined with 3-isobutyl-1-methyl-7H-xanthine.
DB08844
The risk or severity of adverse effects can be increased when Indenolol is combined with Uric acid.
DB11919
The risk or severity of adverse effects can be increased when Indenolol is combined with 6-O-benzylguanine.
DB12406
The risk or severity of adverse effects can be increased when Indenolol is combined with Lisofylline.
DB12531
The risk or severity of adverse effects can be increased when Indenolol is combined with Lobucavir.
DB12926
The risk or severity of adverse effects can be increased when Indenolol is combined with Cafedrine.
DB12927
The risk or severity of adverse effects can be increased when Indenolol is combined with Theodrenaline.
DB13203
The risk or severity of adverse effects can be increased when Indenolol is combined with Bamifylline.
DB13449
The risk or severity of adverse effects can be increased when Indenolol is combined with Proxyphylline.
DB13573
The risk or severity of adverse effects can be increased when Indenolol is combined with Acefylline.
DB13592
The risk or severity of adverse effects can be increased when Indenolol is combined with Etamiphylline.
DB13634
The risk or severity of adverse effects can be increased when Indenolol is combined with Pentifylline.
DB13812
The risk or severity of adverse effects can be increased when Indenolol is combined with Bufylline.
DB14018
The risk or severity of adverse effects can be increased when Indenolol is combined with Bromotheophylline.
DB14029
The risk or severity of adverse effects can be increased when Indenolol is combined with Furafylline.
DB14132
The risk or severity of adverse effects can be increased when Indenolol is combined with 8-chlorotheophylline.
DB15122
The risk or severity of adverse effects can be increased when Indenolol is combined with PCS-499.
DB00521
Carteolol may increase the arrhythmogenic activities of Indenolol.
DB01214
Metipranolol may increase the arrhythmogenic activities of Indenolol.
DB03322
Dexpropranolol may increase the arrhythmogenic activities of Indenolol.
DB00680
Moricizine may increase the arrhythmogenic activities of Indenolol.
DB00390
Indenolol may increase the arrhythmogenic activities of Digoxin.
DB00511
Indenolol may increase the arrhythmogenic activities of Acetyldigitoxin.
DB01078
Indenolol may increase the arrhythmogenic activities of Deslanoside.
DB01396
Indenolol may increase the arrhythmogenic activities of Digitoxin.
DB13240
Indenolol may increase the arrhythmogenic activities of Cymarin.
DB13401
Indenolol may increase the arrhythmogenic activities of Metildigoxin.
DB13691
Indenolol may increase the arrhythmogenic activities of Acetyldigoxin.
DB00222
Indenolol may increase the arrhythmogenic activities of Glimepiride.
DB01056
Tocainide may increase the arrhythmogenic activities of Indenolol.
DB11699
Indenolol may increase the arrhythmogenic activities of Tropisetron.
DB12704
Indenolol may increase the arrhythmogenic activities of Spiradoline.
DB13635
Indenolol may increase the arrhythmogenic activities of Tiracizine.
DB13645
Indenolol may increase the arrhythmogenic activities of Ethacizine.
DB13718
Indenolol may increase the arrhythmogenic activities of Hydroquinine.
DB13746
Indenolol may increase the arrhythmogenic activities of Bioallethrin.
DB13863
Indenolol may increase the arrhythmogenic activities of Fosfructose.
DB15300
Indenolol may increase the arrhythmogenic activities of Hydroquinidine.
DB15366
SOR-C13 may increase the arrhythmogenic activities of Indenolol.
DB00187
Esmolol may increase the arrhythmogenic activities of Indenolol.
DB00230
Pregabalin may increase the arrhythmogenic activities of Indenolol.
DB00424
Hyoscyamine may increase the arrhythmogenic activities of Indenolol.
DB00678
Losartan may increase the arrhythmogenic activities of Indenolol.
DB00825
Levomenthol may increase the arrhythmogenic activities of Indenolol.
DB01158
Bretylium may increase the arrhythmogenic activities of Indenolol.
DB01228
Encainide may increase the arrhythmogenic activities of Indenolol.
DB01426
Ajmaline may increase the arrhythmogenic activities of Indenolol.
DB06217
Vernakalant may increase the arrhythmogenic activities of Indenolol.
DB06468
Cariporide may increase the arrhythmogenic activities of Indenolol.
DB08808
Bupranolol may increase the arrhythmogenic activities of Indenolol.
DB00195
Indenolol may increase the arrhythmogenic activities of Betaxolol.
DB00571
Indenolol may increase the arrhythmogenic activities of Propranolol.
DB00572
Indenolol may increase the arrhythmogenic activities of Atropine.
DB00640
Indenolol may increase the arrhythmogenic activities of Adenosine.
DB00922
Indenolol may increase the arrhythmogenic activities of Levosimendan.
DB01193
Indenolol may increase the arrhythmogenic activities of Acebutolol.
DB01580
Indenolol may increase the arrhythmogenic activities of Oxprenolol.
DB04957
Indenolol may increase the arrhythmogenic activities of Azimilide.
DB06200
Indenolol may increase the arrhythmogenic activities of Tedisamil.
DB09224
Indenolol may increase the arrhythmogenic activities of Melperone.
DB12286
Indenolol may increase the arrhythmogenic activities of Simendan.
DB13546
Indenolol may increase the arrhythmogenic activities of Nizofenone.
DB13652
Indenolol may increase the arrhythmogenic activities of Bunaftine.
DB13653
Indenolol may increase the arrhythmogenic activities of Lorcainide.
DB11770
Talinolol may increase the arrhythmogenic activities of Indenolol.
DB12712
Pilsicainide may increase the arrhythmogenic activities of Indenolol.
DB12766
Cicletanine may increase the arrhythmogenic activities of Indenolol.
DB13358
Cibenzoline may increase the arrhythmogenic activities of Indenolol.
DB13555
Prajmaline may increase the arrhythmogenic activities of Indenolol.
DB13651
Lorajmine may increase the arrhythmogenic activities of Indenolol.
DB00204
Indenolol may increase the arrhythmogenic activities of Dofetilide.
DB00308
Indenolol may increase the arrhythmogenic activities of Ibutilide.
DB00908
Indenolol may increase the arrhythmogenic activities of Quinidine.
DB00335
Atenolol may increase the arrhythmogenic activities of Indenolol.
DB00866
Alprenolol may increase the arrhythmogenic activities of Indenolol.
DB01203
Nadolol may increase the arrhythmogenic activities of Indenolol.
DB01297
Practolol may increase the arrhythmogenic activities of Indenolol.
DB09220
Indenolol may increase the arrhythmogenic activities of Nicorandil.
DB12212
Indenolol may increase the arrhythmogenic activities of Landiolol.
DB13775
Indenolol may increase the arrhythmogenic activities of Tertatolol.
DB14207
Indenolol may increase the arrhythmogenic activities of Fosinoprilat.
DB04846
Indenolol may increase the arrhythmogenic activities of Celiprolol.
DB04861
Indenolol may increase the arrhythmogenic activities of Nebivolol.
DB11785
Indenolol may increase the arrhythmogenic activities of Anisodamine.
DB06727
Sparteine may increase the arrhythmogenic activities of Indenolol.
DB00379
Mexiletine may increase the arrhythmogenic activities of Indenolol.
DB01429
Aprindine may increase the arrhythmogenic activities of Indenolol.
DB00489
Indenolol may increase the arrhythmogenic activities of Sotalol.
DB01035
Indenolol may increase the arrhythmogenic activities of Procainamide.
DB01195
Indenolol may increase the arrhythmogenic activities of Flecainide.
DB00401
The risk or severity of bradycardia can be increased when Nisoldipine is combined with Indenolol.
DB00653
The risk or severity of bradycardia can be increased when Magnesium sulfate is combined with Indenolol.
DB04838
The risk or severity of bradycardia can be increased when Cyclandelate is combined with Indenolol.
DB04841
The risk or severity of bradycardia can be increased when Flunarizine is combined with Indenolol.
DB04920
The risk or severity of bradycardia can be increased when Clevidipine is combined with Indenolol.
DB05885
The risk or severity of bradycardia can be increased when Seletracetam is combined with Indenolol.
DB06446
The risk or severity of bradycardia can be increased when Dotarizine is combined with Indenolol.
DB07615
The risk or severity of bradycardia can be increased when Tranilast is combined with Indenolol.
DB08162
The risk or severity of bradycardia can be increased when Fasudil is combined with Indenolol.
DB08838
The risk or severity of bradycardia can be increased when Agmatine is combined with Indenolol.
DB09230
The risk or severity of bradycardia can be increased when Azelnidipine is combined with Indenolol.
DB09232
The risk or severity of bradycardia can be increased when Cilnidipine is combined with Indenolol.
DB09234
The risk or severity of bradycardia can be increased when Darodipine is combined with Indenolol.
DB09240
The risk or severity of bradycardia can be increased when Niludipine is combined with Indenolol.
DB11960
The risk or severity of bradycardia can be increased when Carboxyamidotriazole is combined with Indenolol.
DB12092
The risk or severity of bradycardia can be increased when Naftopidil is combined with Indenolol.
DB12131
The risk or severity of bradycardia can be increased when Vinpocetine is combined with Indenolol.
DB13835
The risk or severity of bradycardia can be increased when Caroverine is combined with Indenolol.
DB13950
The risk or severity of bradycardia can be increased when WIN 55212-2 is combined with Indenolol.
DB13961
The risk or severity of bradycardia can be increased when Fish oil is combined with Indenolol.
DB14064
The risk or severity of bradycardia can be increased when Emopamil is combined with Indenolol.
DB14065
The risk or severity of bradycardia can be increased when Lomerizine is combined with Indenolol.
DB14066
The risk or severity of bradycardia can be increased when Tetrandrine is combined with Indenolol.
DB14068
The risk or severity of bradycardia can be increased when Dexniguldipine is combined with Indenolol.
DB01136
The risk or severity of bradycardia can be increased when Indenolol is combined with Carvedilol.
DB09239
The risk or severity of bradycardia can be increased when Indenolol is combined with Niguldipine.
DB00343
The risk or severity of bradycardia can be increased when Diltiazem is combined with Indenolol.
DB00393
The risk or severity of bradycardia can be increased when Nimodipine is combined with Indenolol.
DB00568
The risk or severity of bradycardia can be increased when Cinnarizine is combined with Indenolol.
DB00836
The risk or severity of bradycardia can be increased when Loperamide is combined with Indenolol.
DB01388
The risk or severity of bradycardia can be increased when Mibefradil is combined with Indenolol.
DB04825
The risk or severity of bradycardia can be increased when Prenylamine is combined with Indenolol.
DB04842
The risk or severity of bradycardia can be increased when Fluspirilene is combined with Indenolol.
DB06712
The risk or severity of bradycardia can be increased when Nilvadipine is combined with Indenolol.
DB08980
The risk or severity of bradycardia can be increased when Indenolol is combined with Fendiline.
DB08992
The risk or severity of bradycardia can be increased when Indenolol is combined with Eperisone.
DB09231
The risk or severity of bradycardia can be increased when Indenolol is combined with Benidipine.
DB13500
The risk or severity of bradycardia can be increased when Indenolol is combined with Otilonium.
DB13791
The risk or severity of bradycardia can be increased when Indenolol is combined with Penfluridol.
DB14063
The risk or severity of bradycardia can be increased when Indenolol is combined with Dexverapamil.
DB00270
The risk or severity of bradycardia can be increased when Isradipine is combined with Indenolol.
DB00347
The risk or severity of bradycardia can be increased when Trimethadione is combined with Indenolol.
DB00381
The risk or severity of bradycardia can be increased when Amlodipine is combined with Indenolol.
DB00555
The risk or severity of bradycardia can be increased when Lamotrigine is combined with Indenolol.
DB00593
The risk or severity of bradycardia can be increased when Ethosuximide is combined with Indenolol.
DB00909
The risk or severity of bradycardia can be increased when Zonisamide is combined with Indenolol.
DB01023
The risk or severity of bradycardia can be increased when Felodipine is combined with Indenolol.
DB01054
The risk or severity of bradycardia can be increased when Nitrendipine is combined with Indenolol.
DB05246
The risk or severity of bradycardia can be increased when Methsuximide is combined with Indenolol.
DB06283
The risk or severity of bradycardia can be increased when Ziconotide is combined with Indenolol.
DB09089
The risk or severity of bradycardia can be increased when Trimebutine is combined with Indenolol.
DB09090
The risk or severity of bradycardia can be increased when Pinaverium is combined with Indenolol.
DB09229
The risk or severity of bradycardia can be increased when Aranidipine is combined with Indenolol.
DB09235
The risk or severity of bradycardia can be increased when Efonidipine is combined with Indenolol.
DB09236
The risk or severity of bradycardia can be increased when Lacidipine is combined with Indenolol.
DB12093
The risk or severity of bradycardia can be increased when Tetrahydropalmatine is combined with Indenolol.
DB12923
The risk or severity of bradycardia can be increased when Gallopamil is combined with Indenolol.
DB13488
The risk or severity of bradycardia can be increased when Bencyclane is combined with Indenolol.
DB13766
The risk or severity of bradycardia can be increased when Lidoflazine is combined with Indenolol.
DB01244
The risk or severity of bradycardia can be increased when Indenolol is combined with Bepridil.
DB13725
The risk or severity of bradycardia can be increased when Indenolol is combined with Terodiline.
DB06152
The risk or severity of bradycardia can be increased when Indenolol is combined with Nylidrin.
DB06694
The risk or severity of bradycardia can be increased when Indenolol is combined with Xylometazoline.
DB00528
The risk or severity of bradycardia can be increased when Lercanidipine is combined with Indenolol.
DB00590
Indenolol may increase the orthostatic hypotensive activities of Doxazosin.
DB00598
Indenolol may increase the orthostatic hypotensive activities of Labetalol.
DB00692
Indenolol may increase the orthostatic hypotensive activities of Phentolamine.
DB00706
Indenolol may increase the orthostatic hypotensive activities of Tamsulosin.
DB00777
Indenolol may increase the orthostatic hypotensive activities of Propiomazine.
DB00797
Indenolol may increase the orthostatic hypotensive activities of Tolazoline.
DB00925
Indenolol may increase the orthostatic hypotensive activities of Phenoxybenzamine.
DB01162
Indenolol may increase the orthostatic hypotensive activities of Terazosin.
DB01295
Indenolol may increase the orthostatic hypotensive activities of Bevantolol.
DB06153
Indenolol may increase the orthostatic hypotensive activities of Pizotifen.
DB06207
Indenolol may increase the orthostatic hypotensive activities of Silodosin.
DB08950
Indenolol may increase the orthostatic hypotensive activities of Indoramin.
DB09128
Indenolol may increase the orthostatic hypotensive activities of Brexpiprazole.
DB09206
Indenolol may increase the orthostatic hypotensive activities of Trimazosin.
DB12230
Indenolol may increase the orthostatic hypotensive activities of Bunazosin.
DB12278
Indenolol may increase the orthostatic hypotensive activities of Propiverine.
DB12661
Indenolol may increase the orthostatic hypotensive activities of Urapidil.
DB12752
Indenolol may increase the orthostatic hypotensive activities of Bucindolol.
DB00374
Treprostinil may increase the hypotensive activities of Indenolol.
DB01088
Iloprost may increase the hypotensive activities of Indenolol.
DB01240
Epoprostenol may increase the hypotensive activities of Indenolol.
DB14337
Salvia miltiorrhiza root may increase the hypotensive activities of Indenolol.
DB00082
Pegvisomant may increase the bradycardic activities of Indenolol.
DB00382
Tacrine may increase the bradycardic activities of Indenolol.
DB00392
Profenamine may increase the bradycardic activities of Indenolol.
DB00483
Gallamine triethiodide may increase the bradycardic activities of Indenolol.
DB00515
Cisplatin may increase the bradycardic activities of Indenolol.
DB00527
Cinchocaine may increase the bradycardic activities of Indenolol.
DB00545
Pyridostigmine may increase the bradycardic activities of Indenolol.
DB00585
Nizatidine may increase the bradycardic activities of Indenolol.
DB00677
Isoflurophate may increase the bradycardic activities of Indenolol.
DB00711
Diethylcarbamazine may increase the bradycardic activities of Indenolol.
DB00888
Mechlorethamine may increase the bradycardic activities of Indenolol.
DB00941
Hexafluronium may increase the bradycardic activities of Indenolol.
DB00944
Demecarium may increase the bradycardic activities of Indenolol.
DB00981
Physostigmine may increase the bradycardic activities of Indenolol.
DB01010
Edrophonium may increase the bradycardic activities of Indenolol.
DB01043
Memantine may increase the bradycardic activities of Indenolol.
DB01122
Ambenonium may increase the bradycardic activities of Indenolol.
DB01199
Tubocurarine may increase the bradycardic activities of Indenolol.
DB01221
Ketamine may increase the bradycardic activities of Indenolol.
DB01245
Decamethonium may increase the bradycardic activities of Indenolol.
DB01337
Pancuronium may increase the bradycardic activities of Indenolol.
DB01338
Pipecuronium may increase the bradycardic activities of Indenolol.
DB01381
Ginkgo biloba may increase the bradycardic activities of Indenolol.
DB01400
Neostigmine may increase the bradycardic activities of Indenolol.
DB02365
1,10-Phenanthroline may increase the bradycardic activities of Indenolol.
DB04572
Thiotepa may increase the bradycardic activities of Indenolol.
DB04864
Huperzine A may increase the bradycardic activities of Indenolol.
DB04892
Phenserine may increase the bradycardic activities of Indenolol.
DB05386
Regramostim may increase the bradycardic activities of Indenolol.
DB06692
Aprotinin may increase the bradycardic activities of Indenolol.
DB06756
Glycine betaine may increase the bradycardic activities of Indenolol.
DB06774
Capsaicin may increase the bradycardic activities of Indenolol.
DB11473
Metrifonate may increase the bradycardic activities of Indenolol.
DB12482
Acotiamide may increase the bradycardic activities of Indenolol.
DB13058
Methanesulfonyl Fluoride may increase the bradycardic activities of Indenolol.
DB13495
Paraoxon may increase the bradycardic activities of Indenolol.
DB13503
Tyrothricin may increase the bradycardic activities of Indenolol.
DB13668
Ipidacrine may increase the bradycardic activities of Indenolol.
DB13694
Distigmine may increase the bradycardic activities of Indenolol.
DB14031
Tretamine may increase the bradycardic activities of Indenolol.
DB15317
Posiphen may increase the bradycardic activities of Indenolol.
DB00843
Donepezil may increase the bradycardic activities of Indenolol.
DB02845
Methylphosphinic Acid may increase the bradycardic activities of Indenolol.
DB00601
Linezolid may increase the hypotensive activities of Indenolol.
DB00614
Furazolidone may increase the hypotensive activities of Indenolol.
DB00721
Procaine may increase the hypotensive activities of Indenolol.
DB00780
Phenelzine may increase the hypotensive activities of Indenolol.
DB00805
Minaprine may increase the hypotensive activities of Indenolol.
DB01037
Selegiline may increase the hypotensive activities of Indenolol.
DB01168
Procarbazine may increase the hypotensive activities of Indenolol.
DB01171
Moclobemide may increase the hypotensive activities of Indenolol.
DB01247
Isocarboxazid may increase the hypotensive activities of Indenolol.
DB01367
Rasagiline may increase the hypotensive activities of Indenolol.
DB01626
Pargyline may increase the hypotensive activities of Indenolol.
DB04017
Clorgiline may increase the hypotensive activities of Indenolol.
DB04818
Iproniazid may increase the hypotensive activities of Indenolol.
DB04820
Nialamide may increase the hypotensive activities of Indenolol.
DB06654
Safinamide may increase the hypotensive activities of Indenolol.
DB08550
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Indenolol.
DB09243
Hydracarbazine may increase the hypotensive activities of Indenolol.
DB09244
Pirlindole may increase the hypotensive activities of Indenolol.
DB09245
Toloxatone may increase the hypotensive activities of Indenolol.
DB09246
Benmoxin may increase the hypotensive activities of Indenolol.
DB09248
Mebanazine may increase the hypotensive activities of Indenolol.
DB09249
Octamoxin may increase the hypotensive activities of Indenolol.
DB09250
Pheniprazine may increase the hypotensive activities of Indenolol.
DB09251
Phenoxypropazine may increase the hypotensive activities of Indenolol.
DB09252
Pivhydrazine may increase the hypotensive activities of Indenolol.
DB09253
Safrazine may increase the hypotensive activities of Indenolol.
DB09254
Caroxazone may increase the hypotensive activities of Indenolol.
DB13875
Harmaline may increase the hypotensive activities of Indenolol.
DB13876
Brofaromine may increase the hypotensive activities of Indenolol.
DB00241
The serum concentration of Indenolol can be decreased when it is combined with Butalbital.
DB00312
The serum concentration of Indenolol can be decreased when it is combined with Pentobarbital.
DB00418
The serum concentration of Indenolol can be decreased when it is combined with Secobarbital.
DB00474
The serum concentration of Indenolol can be decreased when it is combined with Methohexital.
DB00599
The serum concentration of Indenolol can be decreased when it is combined with Thiopental.
DB00794
The serum concentration of Indenolol can be decreased when it is combined with Primidone.
DB00849
The serum concentration of Indenolol can be decreased when it is combined with Methylphenobarbital.
DB01154
The serum concentration of Indenolol can be decreased when it is combined with Thiamylal.
DB01174
The serum concentration of Indenolol can be decreased when it is combined with Phenobarbital.
DB01351
The serum concentration of Indenolol can be decreased when it is combined with Amobarbital.
DB01355
The serum concentration of Indenolol can be decreased when it is combined with Hexobarbital.
DB01483
The serum concentration of Indenolol can be decreased when it is combined with Barbital.
DB09001
The serum concentration of Indenolol can be decreased when it is combined with Barbexaclone.
DB00237
The serum concentration of Indenolol can be decreased when it is combined with Butabarbital.
DB00907
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Cocaine.
DB11978
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Glasdegib.
DB00215
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Citalopram.
DB00261
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Anagrelide.
DB00283
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Clemastine.
DB00313
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Valproic acid.
DB00365
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Grepafloxacin.
DB00539
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Toremifene.
DB00604
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Cisapride.
DB00619
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Imatinib.
DB00679
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Thioridazine.
DB00685
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Trovafloxacin.
DB00875
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Flupentixol.
DB01169
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Arsenic trioxide.
DB01184
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Domperidone.
DB01208
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Sparfloxacin.
DB01218
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Halofantrine.
DB01267
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Paliperidone.
DB01356
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Lithium cation.
DB01405
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Temafloxacin.
DB01624
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Zuclopenthixol.
DB04844
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Tetrabenazine.
DB04946
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Iloperidone.
DB05294
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Vandetanib.
DB06176
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Romidepsin.
DB06216
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Asenapine.
DB06697
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Artemether.
DB09039
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Eliglustat.
DB11730
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Ribociclib.
DB12161
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Deutetrabenazine.
DB13074
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Macimorelin.
DB00450
The risk or severity of QTc prolongation can be increased when Droperidol is combined with Indenolol.
DB12523
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Mizolastine.
DB01084
The risk or severity of QTc prolongation can be increased when Emedastine is combined with Indenolol.
DB11718
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Encorafenib.
DB00862
The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Indenolol.
DB00107
The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Indenolol.
DB00188
The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Indenolol.
DB00196
The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Indenolol.
DB00245
The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Indenolol.
DB00289
The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Indenolol.
DB00334
The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Indenolol.
DB00341
The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Indenolol.
DB00354
The risk or severity of QTc prolongation can be increased when Buclizine is combined with Indenolol.
DB00366
The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Indenolol.
DB00370
The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Indenolol.
DB00398
The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Indenolol.
DB00405
The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Indenolol.
DB00427
The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Indenolol.
DB00434
The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Indenolol.
DB00467
The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Indenolol.
DB00487
The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Indenolol.
DB00529
The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Indenolol.
DB00582
The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Indenolol.
DB00674
The risk or severity of QTc prolongation can be increased when Galantamine is combined with Indenolol.
DB00691
The risk or severity of QTc prolongation can be increased when Moexipril is combined with Indenolol.
DB00710
The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Indenolol.
DB00714
The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Indenolol.
DB00719
The risk or severity of QTc prolongation can be increased when Azatadine is combined with Indenolol.
DB00734
The risk or severity of QTc prolongation can be increased when Risperidone is combined with Indenolol.
DB00753
The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Indenolol.
DB00817
The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Indenolol.
DB00818
The risk or severity of QTc prolongation can be increased when Propofol is combined with Indenolol.
DB00822
The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Indenolol.
DB00835
The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Indenolol.
DB00915
The risk or severity of QTc prolongation can be increased when Amantadine is combined with Indenolol.
DB00916
The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Indenolol.
DB00920
The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Indenolol.
DB00927
The risk or severity of QTc prolongation can be increased when Famotidine is combined with Indenolol.
DB00934
The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Indenolol.
DB00949
The risk or severity of QTc prolongation can be increased when Felbamate is combined with Indenolol.
DB01036
The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Indenolol.
DB01044
The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Indenolol.
DB01059
The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Indenolol.
DB01071
The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Indenolol.
DB01072
The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Indenolol.
DB01106
The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Indenolol.
DB01166
The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Indenolol.
DB01176
The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Indenolol.
DB01189
The risk or severity of QTc prolongation can be increased when Desflurane is combined with Indenolol.
DB01236
The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Indenolol.
DB01239
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Indenolol.
DB01254
The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Indenolol.
DB01259
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Indenolol.
DB01263
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Indenolol.
DB01591
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Indenolol.
DB01620
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Indenolol.
DB02546
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Indenolol.
DB04576
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Indenolol.
DB04695
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Indenolol.
DB04953
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Indenolol.
DB05465
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Indenolol.
DB06282
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Indenolol.
DB06288
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Indenolol.
DB06663
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Indenolol.
DB06699
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Indenolol.
DB06719
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Indenolol.
DB06788
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Indenolol.
DB06825
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Indenolol.
DB07780
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Indenolol.
DB07841
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Indenolol.
DB08815
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Indenolol.
DB08864
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Indenolol.
DB08871
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Indenolol.
DB08912
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Indenolol.
DB08936
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Indenolol.
DB00007
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Leuprolide.
DB00014
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Goserelin.
DB00199
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Erythromycin.
DB00207
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Azithromycin.
DB00218
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Moxifloxacin.
DB00333
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Methadone.
DB00391
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Sulpiride.
DB00526
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Oxaliplatin.
DB00537
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Ciprofloxacin.
DB00544
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Fluorouracil.
DB00556
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Perflutren.
DB00625
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Efavirenz.
DB00743
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Gadobenic acid.
DB00748
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Carbinoxamine.
DB00757
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Dolasetron.
DB00778
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Roxithromycin.
DB00779
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Nalidixic acid.
DB00827
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Cinoxacin.
DB00889
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Granisetron.
DB00904
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Ondansetron.
DB00967
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Desloratadine.
DB00976
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Telithromycin.
DB00978
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Lomefloxacin.
DB00985
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Dimenhydrinate.
DB01113
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Papaverine.
DB01114
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Chlorpheniramine.
DB01137
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Levofloxacin.
DB01155
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Gemifloxacin.
DB01165
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Ofloxacin.
DB01211
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Clarithromycin.
DB01227
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Levacetylmethadol.
DB01232
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Saquinavir.
DB01599
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Probucol.
DB02638
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Terlipressin.
DB05223
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Pracinostat.
DB05488
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Technetium Tc-99m ciprofloxacin.
DB06160
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Garenoxacin.
DB06334
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Tucidinostat.
DB06402
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Telavancin.
DB06589
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Pazopanib.
DB06600
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Nemonoxacin.
DB08799
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Antazoline.
DB08865
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Crizotinib.
DB08903
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Bedaquiline.
DB09016
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Butriptyline.
DB09078
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Lenvatinib.
DB09555
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Dexchlorpheniramine maleate.
DB11640
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Amifampridine.
DB11830
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Mocetinostat.
DB11841
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Entinostat.
DB12141
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Gilteritinib.
DB12174
The risk or severity of QTc prolongation can be increased when Indenolol is combined with CUDC-101.
DB12376
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Ricolinostat.
DB12565
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Abexinostat.
DB12877
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Oxatomide.
DB13261
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Sitafloxacin.
DB13273
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Sultopride.
DB13679
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Dexchlorpheniramine.
DB14568
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Ivosidenib.
DB08972
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Indenolol.
DB09488
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Indenolol.
DB11390
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Indenolol.
DB11397
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Indenolol.
DB11408
The risk or severity of QTc prolongation can be increased when Famphur is combined with Indenolol.
DB11412
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Indenolol.
DB11443
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Indenolol.
DB11448
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Indenolol.
DB11491
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Indenolol.
DB11511
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Indenolol.
DB11591
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Indenolol.
DB11614
The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Indenolol.
DB11742
The risk or severity of QTc prolongation can be increased when Ebastine is combined with Indenolol.
DB11774
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Indenolol.
DB11891
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Indenolol.
DB11892
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Indenolol.
DB11943
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Indenolol.
DB12231
The risk or severity of QTc prolongation can be increased when Temefos is combined with Indenolol.
DB12245
The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Indenolol.
DB12645
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Indenolol.
DB13627
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Indenolol.
DB13744
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Indenolol.
DB13772
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Indenolol.
DB13823
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Indenolol.
DB14713
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Indenolol.
DB01623
The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Indenolol.
DB01167
The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Indenolol.
DB01601
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Indenolol.
DB00344
The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Indenolol.
DB00845
The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Indenolol.
DB11796
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Indenolol.
DB00751
The risk or severity of QTc prolongation can be increased when Epinastine is combined with Indenolol.
DB11853
The risk or severity of QTc prolongation can be increased when Relugolix is combined with Indenolol.
DB00802
Alfentanil may increase the bradycardic activities of Indenolol.
DB00813
Fentanyl may increase the bradycardic activities of Indenolol.
DB04897
Lucinactant may increase the bradycardic activities of Indenolol.
DB06218
Lacosamide may increase the bradycardic activities of Indenolol.
DB06415
Calfactant may increase the bradycardic activities of Indenolol.
DB06761
Beractant may increase the bradycardic activities of Indenolol.
DB06791
Lanreotide may increase the bradycardic activities of Indenolol.
DB08895
Tofacitinib may increase the bradycardic activities of Indenolol.
DB09113
Indenolol may increase the bradycardic activities of Poractant alfa.
DB00477
The metabolism of Indenolol can be decreased when combined with Chlorpromazine.
DB00476
The metabolism of Indenolol can be decreased when combined with Duloxetine.
DB12693
The metabolism of Indenolol can be decreased when combined with Ritanserin.
DB00622
The metabolism of Nicardipine can be decreased when combined with Indenolol.
DB00752
The metabolism of Indenolol can be decreased when combined with Tranylcypromine.
DB00363
The metabolism of Indenolol can be decreased when combined with Clozapine.
DB00285
The metabolism of Indenolol can be decreased when combined with Venlafaxine.
DB06603
The metabolism of Panobinostat can be decreased when combined with Indenolol.
DB00342
The metabolism of Terfenadine can be decreased when combined with Indenolol.
DB00468
The metabolism of Quinine can be decreased when combined with Indenolol.
DB04868
The metabolism of Nilotinib can be decreased when combined with Indenolol.
DB06708
The metabolism of Lumefantrine can be decreased when combined with Indenolol.
DB00608
The metabolism of Indenolol can be decreased when combined with Chloroquine.
DB01087
The metabolism of Indenolol can be decreased when combined with Primaquine.
DB00264
The metabolism of Indenolol can be decreased when combined with Metoprolol.
DB08893
The metabolism of Mirabegron can be decreased when combined with Indenolol.
DB00091
The metabolism of Indenolol can be decreased when combined with Cyclosporine.
DB00169
The metabolism of Indenolol can be decreased when combined with Cholecalciferol.
DB00176
The metabolism of Indenolol can be decreased when combined with Fluvoxamine.
DB00349
The metabolism of Indenolol can be decreased when combined with Clobazam.
DB00496
The metabolism of Indenolol can be decreased when combined with Darifenacin.
DB00501
The metabolism of Indenolol can be decreased when combined with Cimetidine.
DB00503
The metabolism of Indenolol can be decreased when combined with Ritonavir.
DB00705
The metabolism of Indenolol can be decreased when combined with Delavirdine.
DB00857
The metabolism of Indenolol can be decreased when combined with Terbinafine.
DB00932
The metabolism of Indenolol can be decreased when combined with Tipranavir.
DB01026
The metabolism of Indenolol can be decreased when combined with Ketoconazole.
DB01074
The metabolism of Indenolol can be decreased when combined with Perhexiline.
DB01079
The metabolism of Indenolol can be decreased when combined with Tegaserod.
DB02703
The metabolism of Indenolol can be decreased when combined with Fusidic acid.
DB05812
The metabolism of Indenolol can be decreased when combined with Abiraterone.
DB06684
The metabolism of Indenolol can be decreased when combined with Vilazodone.
DB06729
The metabolism of Indenolol can be decreased when combined with Sulfaphenazole.
DB06819
The metabolism of Indenolol can be decreased when combined with Phenylbutyric acid.
DB09238
The metabolism of Indenolol can be decreased when combined with Manidipine.
DB09291
The metabolism of Indenolol can be decreased when combined with Rolapitant.
DB11586
The metabolism of Indenolol can be decreased when combined with Asunaprevir.
DB12332
The metabolism of Indenolol can be decreased when combined with Rucaparib.
DB13174
The metabolism of Indenolol can be decreased when combined with Rhein.
DB00458
The metabolism of Imipramine can be decreased when combined with Indenolol.
DB01151
The metabolism of Desipramine can be decreased when combined with Indenolol.
DB09167
The metabolism of Dosulepin can be decreased when combined with Indenolol.
DB04871
The metabolism of Indenolol can be decreased when combined with Lorcaserin.
DB15982
The metabolism of Indenolol can be decreased when combined with Berotralstat.
DB00715
The metabolism of Indenolol can be decreased when combined with Paroxetine.
DB01012
The metabolism of Indenolol can be decreased when combined with Cinacalcet.
DB01156
The metabolism of Indenolol can be decreased when combined with Bupropion.
DB01173
The metabolism of Indenolol can be decreased when combined with Orphenadrine.
DB01403
The metabolism of Indenolol can be decreased when combined with Methotrimeprazine.
DB06595
The metabolism of Indenolol can be decreased when combined with Midostaurin.
DB08909
The metabolism of Indenolol can be decreased when combined with Glycerol phenylbutyrate.
DB00358
The risk or severity of QTc prolongation can be decreased when Mefloquine is combined with Indenolol.
DB00613
The risk or severity of QTc prolongation can be decreased when Amodiaquine is combined with Indenolol.
DB01611
The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Indenolol.
DB00177
The risk or severity of hyperkalemia can be increased when Valsartan is combined with Indenolol.
DB00202
The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Indenolol.
DB00275
The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Indenolol.
DB00384
The risk or severity of hyperkalemia can be increased when Triamterene is combined with Indenolol.
DB00407
The risk or severity of hyperkalemia can be increased when Ardeparin is combined with Indenolol.
DB00421
The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Indenolol.
DB00492
The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Indenolol.
DB00519
The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Indenolol.
DB00542
The risk or severity of hyperkalemia can be increased when Benazepril is combined with Indenolol.
DB00584
The risk or severity of hyperkalemia can be increased when Enalapril is combined with Indenolol.
DB00594
The risk or severity of hyperkalemia can be increased when Amiloride is combined with Indenolol.
DB00698
The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Indenolol.
DB00700
The risk or severity of hyperkalemia can be increased when Eplerenone is combined with Indenolol.
DB00722
The risk or severity of hyperkalemia can be increased when Lisinopril is combined with Indenolol.
DB00742
The risk or severity of hyperkalemia can be increased when Mannitol is combined with Indenolol.
DB00796
The risk or severity of hyperkalemia can be increased when Candesartan cilexetil is combined with Indenolol.
DB00876
The risk or severity of hyperkalemia can be increased when Eprosartan is combined with Indenolol.
DB00881
The risk or severity of hyperkalemia can be increased when Quinapril is combined with Indenolol.
DB00886
The risk or severity of hyperkalemia can be increased when Omapatrilat is combined with Indenolol.
DB00960
The risk or severity of hyperkalemia can be increased when Pindolol is combined with Indenolol.
DB00966
The risk or severity of hyperkalemia can be increased when Telmisartan is combined with Indenolol.
DB01029
The risk or severity of hyperkalemia can be increased when Irbesartan is combined with Indenolol.
DB01109
The risk or severity of hyperkalemia can be increased when Heparin is combined with Indenolol.
DB01180
The risk or severity of hyperkalemia can be increased when Rescinnamine is combined with Indenolol.
DB01197
The risk or severity of hyperkalemia can be increased when Captopril is combined with Indenolol.
DB01219
The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Indenolol.
DB01225
The risk or severity of hyperkalemia can be increased when Enoxaparin is combined with Indenolol.
DB01340
The risk or severity of hyperkalemia can be increased when Cilazapril is combined with Indenolol.
DB01342
The risk or severity of hyperkalemia can be increased when Forasartan is combined with Indenolol.
DB01347
The risk or severity of hyperkalemia can be increased when Saprisartan is combined with Indenolol.
DB01348
The risk or severity of hyperkalemia can be increased when Spirapril is combined with Indenolol.
DB01349
The risk or severity of hyperkalemia can be increased when Tasosartan is combined with Indenolol.
DB01359
The risk or severity of hyperkalemia can be increased when Penbutolol is combined with Indenolol.
DB01395
The risk or severity of hyperkalemia can be increased when Drospirenone is combined with Indenolol.
DB02968
The risk or severity of hyperkalemia can be increased when Penicillin G Acyl-Serine is combined with Indenolol.
DB06212
The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Indenolol.
DB06271
The risk or severity of hyperkalemia can be increased when Sulodexide is combined with Indenolol.
DB06726
The risk or severity of hyperkalemia can be increased when Bufuralol is combined with Indenolol.
DB06754
The risk or severity of hyperkalemia can be increased when Danaparoid is combined with Indenolol.
DB06763
The risk or severity of hyperkalemia can be increased when Saralasin is combined with Indenolol.
DB06767
The risk or severity of hyperkalemia can be increased when Ammonium chloride is combined with Indenolol.
DB06779
The risk or severity of hyperkalemia can be increased when Dalteparin is combined with Indenolol.
DB06822
The risk or severity of hyperkalemia can be increased when Tinzaparin is combined with Indenolol.
DB08807
The risk or severity of hyperkalemia can be increased when Bopindolol is combined with Indenolol.
DB08813
The risk or severity of hyperkalemia can be increased when Nadroparin is combined with Indenolol.
DB08822
The risk or severity of hyperkalemia can be increased when Azilsartan medoxomil is combined with Indenolol.
DB08836
The risk or severity of hyperkalemia can be increased when Temocapril is combined with Indenolol.
DB09015
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Canrenoic acid.
DB09026
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Aliskiren.
DB09204
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Arotinolol.
DB09258
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Bemiparin.
DB09259
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Reviparin.
DB09260
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Parnaparin.
DB09261
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Certoparin.
DB09279
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Fimasartan.
DB09351
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Levobetaxolol.
DB09477
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Enalaprilat.
DB11783
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Imidapril.
DB12097
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Mannitol busulfan.
DB12221
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Canrenone.
DB13166
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Zofenopril.
DB13312
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Delapril.
DB13443
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Esatenolol.
DB13508
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Cloranolol.
DB13530
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Mepindolol.
DB13757
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Epanolol.
DB13919
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Candesartan.
DB14125
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Benazeprilat.
DB14208
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Ramiprilat.
DB14213
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Perindoprilat.
DB14217
The risk or severity of hyperkalemia can be increased when Indenolol is combined with Quinaprilat.
DB00440
The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Indenolol.
DB10349
The risk of a hypersensitivity reaction to Paspalum notatum pollen is increased when it is combined with Indenolol.
DB10351
The risk of a hypersensitivity reaction to Cynodon dactylon pollen is increased when it is combined with Indenolol.
DB10353
The risk of a hypersensitivity reaction to Poa annua pollen is increased when it is combined with Indenolol.
DB10365
The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Indenolol.
DB10366
The risk of a hypersensitivity reaction to Poa pratensis pollen is increased when it is combined with Indenolol.
DB10370
The risk of a hypersensitivity reaction to Festuca pratensis pollen is increased when it is combined with Indenolol.
DB10379
The risk of a hypersensitivity reaction to Dactylis glomerata pollen is increased when it is combined with Indenolol.
DB10389
The risk of a hypersensitivity reaction to Lolium perenne pollen is increased when it is combined with Indenolol.
DB10394
The risk of a hypersensitivity reaction to Phleum pratense pollen is increased when it is combined with Indenolol.
DB10395
The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Indenolol.
DB10403
The risk of a hypersensitivity reaction to Agrostis gigantea pollen is increased when it is combined with Indenolol.
DB10404
The risk of a hypersensitivity reaction to Anthoxanthum odoratum pollen is increased when it is combined with Indenolol.
DB10489
The risk of a hypersensitivity reaction to Elymus repens pollen is increased when it is combined with Indenolol.
DB10494
The risk of a hypersensitivity reaction to Distichlis spicata pollen is increased when it is combined with Indenolol.
DB10713
The risk of a hypersensitivity reaction to Poa compressa pollen is increased when it is combined with Indenolol.
DB10714
The risk of a hypersensitivity reaction to Phalaris arundinacea pollen is increased when it is combined with Indenolol.
DB10715
The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Indenolol.
DB10716
The risk of a hypersensitivity reaction to Urochloa mutica pollen is increased when it is combined with Indenolol.
DB10717
The risk of a hypersensitivity reaction to Secale cereale pollen is increased when it is combined with Indenolol.
DB10719
The risk of a hypersensitivity reaction to Pascopyrum smithii pollen is increased when it is combined with Indenolol.
DB10836
The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Indenolol.
DB10879
The risk of a hypersensitivity reaction to Arrhenatherum elatius pollen is increased when it is combined with Indenolol.
DB10949
The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Indenolol.
DB10962
The risk of a hypersensitivity reaction to Agrostis stolonifera pollen is increased when it is combined with Indenolol.
DB10963
The risk of a hypersensitivity reaction to Phalaris minor pollen is increased when it is combined with Indenolol.
DB10964
The risk of a hypersensitivity reaction to Lolium perenne subsp. multiflorum pollen is increased when it is combined with Indenolol.
DB10966
The risk of a hypersensitivity reaction to Sorghum bicolor subsp. drummondii pollen is increased when it is combined with Indenolol.
DB01045
The metabolism of Indenolol can be increased when combined with Rifampicin.
DB01201
The metabolism of Indenolol can be increased when combined with Rifapentine.
DB01220
The metabolism of Indenolol can be increased when combined with Rifaximin.
DB11753
The metabolism of Indenolol can be increased when combined with Rifamycin.
DB15213
The metabolism of Indenolol can be increased when combined with 25-desacetylrifapentine.
DB08881
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Vemurafenib.
DB09227
Indenolol may increase the antihypertensive activities of Barnidipine.
DB11637
Indenolol may increase the QTc-prolonging activities of Delamanid.
DB13967
The risk or severity of hypersensitivity reaction can be increased when Patent Blue is combined with Indenolol.
DB00217
The therapeutic efficacy of Bethanidine can be decreased when used in combination with Indenolol.
DB00221
The therapeutic efficacy of Isoetharine can be decreased when used in combination with Indenolol.
DB00292
The therapeutic efficacy of Etomidate can be decreased when used in combination with Indenolol.
DB00368
The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Indenolol.
DB00388
The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Indenolol.
DB00397
The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Indenolol.
DB00610
The therapeutic efficacy of Metaraminol can be decreased when used in combination with Indenolol.
DB00629
The therapeutic efficacy of Guanabenz can be decreased when used in combination with Indenolol.
DB00633
The therapeutic efficacy of Dexmedetomidine can be decreased when used in combination with Indenolol.
DB00668
The therapeutic efficacy of Epinephrine can be decreased when used in combination with Indenolol.
DB00697
The therapeutic efficacy of Tizanidine can be decreased when used in combination with Indenolol.
DB00723
The therapeutic efficacy of Methoxamine can be decreased when used in combination with Indenolol.
DB00816
The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Indenolol.
DB00841
The therapeutic efficacy of Dobutamine can be decreased when used in combination with Indenolol.
DB00867
The therapeutic efficacy of Ritodrine can be decreased when used in combination with Indenolol.
DB00871
The therapeutic efficacy of Terbutaline can be decreased when used in combination with Indenolol.
DB00901
The therapeutic efficacy of Bitolterol can be decreased when used in combination with Indenolol.
DB00935
The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Indenolol.
DB00938
The therapeutic efficacy of Salmeterol can be decreased when used in combination with Indenolol.
DB00968
The therapeutic efficacy of Methyldopa can be decreased when used in combination with Indenolol.
DB00983
The therapeutic efficacy of Formoterol can be decreased when used in combination with Indenolol.
DB01001
The therapeutic efficacy of Salbutamol can be decreased when used in combination with Indenolol.
DB01018
The therapeutic efficacy of Guanfacine can be decreased when used in combination with Indenolol.
DB01064
The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Indenolol.
DB01102
The therapeutic efficacy of Arbutamine can be decreased when used in combination with Indenolol.
DB01186
The therapeutic efficacy of Pergolide can be decreased when used in combination with Indenolol.
DB01253
The therapeutic efficacy of Ergometrine can be decreased when used in combination with Indenolol.
DB01274
The therapeutic efficacy of Arformoterol can be decreased when used in combination with Indenolol.
DB01288
The therapeutic efficacy of Fenoterol can be decreased when used in combination with Indenolol.
DB01291
The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Indenolol.
DB01363
The therapeutic efficacy of Ephedra sinica root can be decreased when used in combination with Indenolol.
DB01364
The therapeutic efficacy of Ephedrine can be decreased when used in combination with Indenolol.
DB01366
The therapeutic efficacy of Procaterol can be decreased when used in combination with Indenolol.
DB01407
The therapeutic efficacy of Clenbuterol can be decreased when used in combination with Indenolol.
DB01408
The therapeutic efficacy of Bambuterol can be decreased when used in combination with Indenolol.
DB01472
The therapeutic efficacy of 4-Methoxyamphetamine can be decreased when used in combination with Indenolol.
DB01537
The therapeutic efficacy of 4-Bromo-2,5-dimethoxyphenethylamine can be decreased when used in combination with Indenolol.
DB01579
The therapeutic efficacy of Phendimetrazine can be decreased when used in combination with Indenolol.
DB04948
The therapeutic efficacy of Lofexidine can be decreased when used in combination with Indenolol.
DB05039
The therapeutic efficacy of Indacaterol can be decreased when used in combination with Indenolol.
DB05395
The therapeutic efficacy of Amibegron can be decreased when used in combination with Indenolol.
DB06190
The therapeutic efficacy of Solabegron can be decreased when used in combination with Indenolol.
DB06262
The therapeutic efficacy of Droxidopa can be decreased when used in combination with Indenolol.
DB06706
The therapeutic efficacy of Isometheptene can be decreased when used in combination with Indenolol.
DB06707
The therapeutic efficacy of Levonordefrin can be decreased when used in combination with Indenolol.
DB06711
The therapeutic efficacy of Naphazoline can be decreased when used in combination with Indenolol.
DB06764
The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Indenolol.
DB06814
The therapeutic efficacy of Protokylol can be decreased when used in combination with Indenolol.
DB08925
The therapeutic efficacy of Adrafinil can be decreased when used in combination with Indenolol.
DB08941
The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Indenolol.
DB08957
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Indenolol.
DB08985
The therapeutic efficacy of Etilefrine can be decreased when used in combination with Indenolol.
DB09080
The therapeutic efficacy of Olodaterol can be decreased when used in combination with Indenolol.
DB09082
The therapeutic efficacy of Vilanterol can be decreased when used in combination with Indenolol.
DB09202
The therapeutic efficacy of Cirazoline can be decreased when used in combination with Indenolol.
DB09203
The therapeutic efficacy of Synephrine can be decreased when used in combination with Indenolol.
DB09242
The therapeutic efficacy of Moxonidine can be decreased when used in combination with Indenolol.
DB09273
The therapeutic efficacy of Doxofylline can be decreased when used in combination with Indenolol.
DB11124
The therapeutic efficacy of Racepinephrine can be decreased when used in combination with Indenolol.
DB11278
The therapeutic efficacy of DL-Methylephedrine can be decreased when used in combination with Indenolol.
DB11373
The therapeutic efficacy of Amitraz can be decreased when used in combination with Indenolol.
DB11428
The therapeutic efficacy of Medetomidine can be decreased when used in combination with Indenolol.
DB11477
The therapeutic efficacy of Xylazine can be decreased when used in combination with Indenolol.
DB11541
The therapeutic efficacy of Ractopamine can be decreased when used in combination with Indenolol.
DB11543
The therapeutic efficacy of Romifidine can be decreased when used in combination with Indenolol.
DB11556
The therapeutic efficacy of Detomidine can be decreased when used in combination with Indenolol.
DB11587
The therapeutic efficacy of Etafedrine can be decreased when used in combination with Indenolol.
DB11738
The therapeutic efficacy of Rilmenidine can be decreased when used in combination with Indenolol.
DB11871
The therapeutic efficacy of PF-00610355 can be decreased when used in combination with Indenolol.
DB12100
The therapeutic efficacy of Abediterol can be decreased when used in combination with Indenolol.
DB12248
The therapeutic efficacy of Tulobuterol can be decreased when used in combination with Indenolol.
DB12313
The therapeutic efficacy of Dopexamine can be decreased when used in combination with Indenolol.
DB12526
The therapeutic efficacy of Batefenterol can be decreased when used in combination with Indenolol.
DB12779
The therapeutic efficacy of Higenamine can be decreased when used in combination with Indenolol.
DB12846
The therapeutic efficacy of Reproterol can be decreased when used in combination with Indenolol.
DB13139
The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Indenolol.
DB13251
The therapeutic efficacy of Octopamine can be decreased when used in combination with Indenolol.
DB13378
The therapeutic efficacy of Norfenefrine can be decreased when used in combination with Indenolol.
DB13398
The therapeutic efficacy of Oxyfedrine can be decreased when used in combination with Indenolol.
DB13559
The therapeutic efficacy of Rimiterol can be decreased when used in combination with Indenolol.
DB13692
The therapeutic efficacy of Tretoquinol can be decreased when used in combination with Indenolol.
DB13777
The therapeutic efficacy of Prenalterol can be decreased when used in combination with Indenolol.
DB13781
The therapeutic efficacy of Xamoterol can be decreased when used in combination with Indenolol.
DB14752
The therapeutic efficacy of Racephedrine can be decreased when used in combination with Indenolol.
DB14547
The therapeutic efficacy of Chloride ion can be decreased when used in combination with Indenolol.
DB00864
The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Indenolol.
DB00761
Potassium chloride may increase the hyperkalemic activities of Indenolol.
DB09125
Indenolol may increase the hyperkalemic activities of Potassium citrate.
DB11098
Indenolol may increase the hyperkalemic activities of Potassium bicarbonate.
DB14498
Indenolol may increase the hyperkalemic activities of Potassium acetate.
DB09087
Potassium alum may increase the hyperkalemic activities of Indenolol.
DB09413
Monopotassium phosphate may increase the hyperkalemic activities of Indenolol.
DB09414
Dipotassium phosphate may increase the hyperkalemic activities of Indenolol.
DB09449
Sodium phosphate, monobasic may increase the hyperkalemic activities of Indenolol.
DB09483
Potassium lactate may increase the hyperkalemic activities of Indenolol.
DB11090
Potassium nitrate may increase the hyperkalemic activities of Indenolol.
DB11107
Potassium bitartrate may increase the hyperkalemic activities of Indenolol.
DB11153
Potassium hydroxide may increase the hyperkalemic activities of Indenolol.
DB13620
Potassium gluconate may increase the hyperkalemic activities of Indenolol.
DB13735
Potassium guaiacolsulfonate may increase the hyperkalemic activities of Indenolol.
DB13831
Potassium permanganate may increase the hyperkalemic activities of Indenolol.
DB13977
Potassium carbonate may increase the hyperkalemic activities of Indenolol.
DB14492
Potassium triiodide may increase the hyperkalemic activities of Indenolol.
DB14499
Potassium sulfate may increase the hyperkalemic activities of Indenolol.
DB14500
Potassium may increase the hyperkalemic activities of Indenolol.
DB06715
Potassium Iodide may increase the hyperkalemic activities of Indenolol.
DB09418
Potassium perchlorate may increase the hyperkalemic activities of Indenolol.
DB01345
Potassium cation may increase the hyperkalemic activities of Indenolol.
DB09061
The metabolism of Indenolol can be decreased when combined with Cannabidiol.
DB00208
The metabolism of Indenolol can be decreased when combined with Ticlopidine.
DB00439
The metabolism of Indenolol can be decreased when combined with Cerivastatin.
DB00574
The metabolism of Indenolol can be decreased when combined with Fenfluramine.
DB00647
The metabolism of Indenolol can be decreased when combined with Dextropropoxyphene.
DB00792
The metabolism of Indenolol can be decreased when combined with Tripelennamine.
DB00810
The metabolism of Indenolol can be decreased when combined with Biperiden.
DB00997
The metabolism of Indenolol can be decreased when combined with Doxorubicin.
DB01005
The metabolism of Indenolol can be decreased when combined with Hydroxyurea.
DB01075
The metabolism of Indenolol can be decreased when combined with Diphenhydramine.
DB01110
The metabolism of Indenolol can be decreased when combined with Miconazole.
DB01128
The metabolism of Indenolol can be decreased when combined with Bicalutamide.
DB01233
The metabolism of Indenolol can be decreased when combined with Metoclopramide.
DB05271
The metabolism of Indenolol can be decreased when combined with Rotigotine.
DB06204
The metabolism of Indenolol can be decreased when combined with Tapentadol.
DB06370
The metabolism of Indenolol can be decreased when combined with Indisulam.
DB06412
The metabolism of Indenolol can be decreased when combined with Oxymetholone.
DB09049
The metabolism of Indenolol can be decreased when combined with Naloxegol.
DB09118
The metabolism of Indenolol can be decreased when combined with Stiripentol.
DB11633
The metabolism of Indenolol can be decreased when combined with Isavuconazole.
DB11638
The metabolism of Indenolol can be decreased when combined with Artenimol.
DB11994
The metabolism of Indenolol can be decreased when combined with Diacerein.
DB13975
The metabolism of Indenolol can be decreased when combined with Black cohosh.
DB01062
The metabolism of Indenolol can be decreased when combined with Oxybutynin.
DB01093
The metabolism of Indenolol can be decreased when combined with Dimethyl sulfoxide.
DB00972
The metabolism of Indenolol can be decreased when combined with Azelastine.
DB00220
The metabolism of Indenolol can be decreased when combined with Nelfinavir.
DB06691
The metabolism of Indenolol can be decreased when combined with Mepyramine.
DB01096
The metabolism of Indenolol can be decreased when combined with Oxamniquine.
DB01562
The metabolism of Indenolol can be decreased when combined with 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine.
DB14009
The metabolism of Indenolol can be decreased when combined with Medical Cannabis.
DB14011
The metabolism of Indenolol can be decreased when combined with Nabiximols.
DB14635
The metabolism of Indenolol can be decreased when combined with Curcumin sulfate.
DB01590
The metabolism of Indenolol can be decreased when combined with Everolimus.
DB00863
The metabolism of Indenolol can be decreased when combined with Ranitidine.
DB00627
The metabolism of Indenolol can be decreased when combined with Niacin.
DB01142
The metabolism of Indenolol can be decreased when combined with Doxepin.
DB12500
The metabolism of Indenolol can be decreased when combined with Fedratinib.
DB00022
The metabolism of Indenolol can be decreased when combined with Peginterferon alfa-2b.
DB00209
The metabolism of Indenolol can be decreased when combined with Trospium.
DB00227
The metabolism of Indenolol can be decreased when combined with Lovastatin.
DB00234
The metabolism of Indenolol can be decreased when combined with Reboxetine.
DB00238
The metabolism of Indenolol can be decreased when combined with Nevirapine.
DB00317
The metabolism of Indenolol can be decreased when combined with Gefitinib.
DB00338
The metabolism of Indenolol can be decreased when combined with Omeprazole.
DB00361
The metabolism of Indenolol can be decreased when combined with Vinorelbine.
DB00448
The metabolism of Indenolol can be decreased when combined with Lansoprazole.
DB00494
The metabolism of Indenolol can be decreased when combined with Entacapone.
DB00570
The metabolism of Indenolol can be decreased when combined with Vinblastine.
DB00921
The metabolism of Indenolol can be decreased when combined with Buprenorphine.
DB01129
The metabolism of Indenolol can be decreased when combined with Rabeprazole.
DB01131
The metabolism of Indenolol can be decreased when combined with Proguanil.
DB01191
The metabolism of Indenolol can be decreased when combined with Dexfenfluramine.
DB01323
The metabolism of Indenolol can be decreased when combined with St. John's Wort.
DB04938
The metabolism of Indenolol can be decreased when combined with Ospemifene.
DB06287
The metabolism of Indenolol can be decreased when combined with Temsirolimus.
DB06512
The metabolism of Indenolol can be decreased when combined with Deramciclane.
DB09065
The metabolism of Indenolol can be decreased when combined with Cobicistat.
DB11837
The metabolism of Indenolol can be decreased when combined with Osilodrostat.
DB04911
The metabolism of Indenolol can be decreased when combined with Oritavancin.
DB00193
The metabolism of Indenolol can be decreased when combined with Tramadol.
DB00216
The metabolism of Indenolol can be decreased when combined with Eletriptan.
DB00316
The metabolism of Indenolol can be decreased when combined with Acetaminophen.
DB00318
The metabolism of Indenolol can be decreased when combined with Codeine.
DB00356
The metabolism of Indenolol can be decreased when combined with Chlorzoxazone.
DB00377
The metabolism of Indenolol can be decreased when combined with Palonosetron.
DB00396
The metabolism of Indenolol can be decreased when combined with Progesterone.
DB00409
The metabolism of Indenolol can be decreased when combined with Remoxipride.
DB00425
The metabolism of Indenolol can be decreased when combined with Zolpidem.
DB00490
The metabolism of Indenolol can be decreased when combined with Buspirone.
DB00497
The metabolism of Indenolol can be decreased when combined with Oxycodone.
DB00514
The metabolism of Indenolol can be decreased when combined with Dextromethorphan.
DB00592
The metabolism of Indenolol can be decreased when combined with Piperazine.
DB00641
The metabolism of Indenolol can be decreased when combined with Simvastatin.
DB00701
The metabolism of Indenolol can be decreased when combined with Amprenavir.
DB00737
The metabolism of Indenolol can be decreased when combined with Meclizine.
DB00918
The metabolism of Indenolol can be decreased when combined with Almotriptan.
DB01028
The metabolism of Indenolol can be decreased when combined with Methoxyflurane.
DB01095
The metabolism of Indenolol can be decreased when combined with Fluvastatin.
DB01177
The metabolism of Indenolol can be decreased when combined with Idarubicin.
DB01192
The metabolism of Indenolol can be decreased when combined with Oxymorphone.
DB01409
The metabolism of Indenolol can be decreased when combined with Tiotropium.
DB01466
The metabolism of Indenolol can be decreased when combined with Ethylmorphine.
DB01551
The metabolism of Indenolol can be decreased when combined with Dihydrocodeine.
DB03783
The metabolism of Indenolol can be decreased when combined with Phenacetin.
DB04905
The metabolism of Indenolol can be decreased when combined with Tesmilifene.
DB06016
The metabolism of Indenolol can be decreased when combined with Cariprazine.
DB06144
The metabolism of Indenolol can be decreased when combined with Sertindole.
DB06148
The metabolism of Indenolol can be decreased when combined with Mianserin.
DB06506
The metabolism of Indenolol can be decreased when combined with Repinotan.
DB06608
The metabolism of Indenolol can be decreased when combined with Tafenoquine.
DB06678
The metabolism of Indenolol can be decreased when combined with Esmirtazapine.
DB06702
The metabolism of Indenolol can be decreased when combined with Fesoterodine.
DB06735
The metabolism of Indenolol can be decreased when combined with Enclomiphene.
DB06770
The metabolism of Indenolol can be decreased when combined with Benzyl alcohol.
DB08922
The metabolism of Indenolol can be decreased when combined with Perospirone.
DB09048
The metabolism of Netupitant can be decreased when combined with Indenolol.
DB09053
The metabolism of Ibrutinib can be decreased when combined with Indenolol.
DB09068
The metabolism of Vortioxetine can be decreased when combined with Indenolol.
DB09076
The metabolism of Umeclidinium can be decreased when combined with Indenolol.
DB09183
The metabolism of Dasabuvir can be decreased when combined with Indenolol.
DB09195
The metabolism of Lorpiprazole can be decreased when combined with Indenolol.
DB11130
The metabolism of Opium can be decreased when combined with Indenolol.
DB11855
The metabolism of Revefenacin can be decreased when combined with Indenolol.
DB11915
The metabolism of Valbenazine can be decreased when combined with Indenolol.
DB11979
The metabolism of Elagolix can be decreased when combined with Indenolol.
DB12070
The metabolism of Letermovir can be decreased when combined with Indenolol.
DB13293
The metabolism of Ipecac can be decreased when combined with Indenolol.
DB09173
The metabolism of Butyrfentanyl can be decreased when combined with Indenolol.
DB11757
The metabolism of Istradefylline can be decreased when combined with Indenolol.
DB01410
The metabolism of Indenolol can be decreased when combined with Ciclesonide.
DB04889
The metabolism of Indenolol can be decreased when combined with Bicifadine.
DB00252
The metabolism of Indenolol can be decreased when combined with Phenytoin.
DB00454
The metabolism of Indenolol can be decreased when combined with Meperidine.
DB00532
The metabolism of Indenolol can be decreased when combined with Mephenytoin.
DB14881
The metabolism of Oliceridine can be decreased when combined with Indenolol.
DB00675
The metabolism of Indenolol can be decreased when combined with Tamoxifen.
DB00530
The metabolism of Erlotinib can be decreased when combined with Indenolol.
DB00637
The metabolism of Astemizole can be decreased when combined with Indenolol.
DB11963
The metabolism of Indenolol can be decreased when combined with Dacomitinib.
DB13874
The metabolism of Indenolol can be decreased when combined with Enasidenib.
DB05109
The metabolism of Indenolol can be decreased when combined with Trabectedin.
DB08901
The metabolism of Indenolol can be decreased when combined with Ponatinib.
DB00277
The metabolism of Theophylline can be decreased when combined with Indenolol.
DB01100
The metabolism of Pimozide can be decreased when combined with Indenolol.
DB00321
The metabolism of Indenolol can be decreased when combined with Amitriptyline.
DB00540
The metabolism of Indenolol can be decreased when combined with Nortriptyline.
DB00543
The metabolism of Indenolol can be decreased when combined with Amoxapine.
DB00726
The metabolism of Indenolol can be decreased when combined with Trimipramine.
DB01242
The metabolism of Indenolol can be decreased when combined with Clomipramine.
DB00181
The risk or severity of adverse effects can be increased when Baclofen is combined with Indenolol.
DB00258
The therapeutic efficacy of Indenolol can be decreased when used in combination with Calcium acetate.
DB00326
The therapeutic efficacy of Indenolol can be decreased when used in combination with Calcium glucoheptonate.
DB01164
The therapeutic efficacy of Indenolol can be decreased when used in combination with Calcium chloride.
DB01373
The therapeutic efficacy of Indenolol can be decreased when used in combination with Calcium.
DB06724
The therapeutic efficacy of Indenolol can be decreased when used in combination with Calcium carbonate.
DB11093
The therapeutic efficacy of Indenolol can be decreased when used in combination with Calcium citrate.
DB11126
The therapeutic efficacy of Indenolol can be decreased when used in combination with Calcium gluconate.
DB11348
The therapeutic efficacy of Indenolol can be decreased when used in combination with Calcium Phosphate.
DB13142
The therapeutic efficacy of Indenolol can be decreased when used in combination with Calcium glubionate anhydrous.
DB13231
The therapeutic efficacy of Indenolol can be decreased when used in combination with Calcium lactate.
DB13365
The therapeutic efficacy of Indenolol can be decreased when used in combination with Calcium lactate gluconate.
DB13590
The therapeutic efficacy of Indenolol can be decreased when used in combination with Calcium pangamate.
DB13800
The therapeutic efficacy of Indenolol can be decreased when used in combination with Calcium levulinate.
DB14577
The therapeutic efficacy of Indenolol can be decreased when used in combination with Calcium cation.
DB14684
The therapeutic efficacy of Indenolol can be decreased when used in combination with Calcium polycarbophil.
DB13917
The therapeutic efficacy of Indenolol can be increased when used in combination with Deoxyepinephrine.
DB00005
The metabolism of Indenolol can be increased when combined with Etanercept.
DB00026
The metabolism of Indenolol can be increased when combined with Anakinra.
DB00051
The metabolism of Indenolol can be increased when combined with Adalimumab.
DB00065
The metabolism of Indenolol can be increased when combined with Infliximab.
DB01281
The metabolism of Indenolol can be increased when combined with Abatacept.
DB04956
The metabolism of Indenolol can be increased when combined with Afelimomab.
DB05676
The metabolism of Indenolol can be increased when combined with Apremilast.
DB06168
The metabolism of Indenolol can be increased when combined with Canakinumab.
DB06273
The metabolism of Indenolol can be increased when combined with Tocilizumab.
DB06372
The metabolism of Indenolol can be increased when combined with Rilonacept.
DB06674
The metabolism of Indenolol can be increased when combined with Golimumab.
DB08904
The metabolism of Indenolol can be increased when combined with Certolizumab pegol.
DB09029
The metabolism of Indenolol can be increased when combined with Secukinumab.
DB09036
The metabolism of Indenolol can be increased when combined with Siltuximab.
DB14724
The metabolism of Indenolol can be increased when combined with Emapalumab.
DB00182
The therapeutic efficacy of Indenolol can be decreased when used in combination with Amphetamine.
DB00191
The therapeutic efficacy of Indenolol can be decreased when used in combination with Phentermine.
DB00852
The therapeutic efficacy of Indenolol can be decreased when used in combination with Pseudoephedrine.
DB00865
The therapeutic efficacy of Indenolol can be decreased when used in combination with Benzphetamine.
DB00937
The therapeutic efficacy of Indenolol can be decreased when used in combination with Diethylpropion.
DB01255
The therapeutic efficacy of Indenolol can be decreased when used in combination with Lisdexamfetamine.
DB01365
The therapeutic efficacy of Indenolol can be decreased when used in combination with Mephentermine.
DB01442
The therapeutic efficacy of Indenolol can be decreased when used in combination with MMDA.
DB01454
The therapeutic efficacy of Indenolol can be decreased when used in combination with Midomafetamine.
DB01467
The therapeutic efficacy of Indenolol can be decreased when used in combination with 2,5-Dimethoxy-4-ethylamphetamine.
DB01484
The therapeutic efficacy of Indenolol can be decreased when used in combination with 4-Bromo-2,5-dimethoxyamphetamine.
DB01509
The therapeutic efficacy of Indenolol can be decreased when used in combination with Tenamfetamine.
DB01556
The therapeutic efficacy of Indenolol can be decreased when used in combination with Chlorphentermine.
DB01566
The therapeutic efficacy of Indenolol can be decreased when used in combination with Methylenedioxyethamphetamine.
DB01576
The therapeutic efficacy of Indenolol can be decreased when used in combination with Dextroamphetamine.
DB01577
The therapeutic efficacy of Indenolol can be decreased when used in combination with Metamfetamine.
DB09480
The therapeutic efficacy of Indenolol can be decreased when used in combination with Iofetamine I-123.
DB12080
The therapeutic efficacy of Indenolol can be decreased when used in combination with Ritobegron.
DB13108
The therapeutic efficacy of Indenolol can be decreased when used in combination with Mephedrone.
DB13624
The therapeutic efficacy of Indenolol can be decreased when used in combination with Methoxyphenamine.
DB13703
The therapeutic efficacy of Indenolol can be decreased when used in combination with Gepefrine.
DB13940
The therapeutic efficacy of Indenolol can be decreased when used in combination with 2,5-Dimethoxy-4-ethylthioamphetamine.
DB00190
The risk or severity of hypotension can be increased when Carbidopa is combined with Indenolol.
DB00228
Enflurane may increase the cardiodepressant activities of Indenolol.
DB00024
The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Indenolol.
DB00279
The therapeutic efficacy of Liothyronine can be decreased when used in combination with Indenolol.
DB00451
The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Indenolol.
DB01583
The therapeutic efficacy of Liotrix can be decreased when used in combination with Indenolol.
DB03604
The therapeutic efficacy of Tiratricol can be decreased when used in combination with Indenolol.
DB09100
The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Indenolol.
DB00457
The risk or severity of hypotension can be increased when Prazosin is combined with Indenolol.
DB00041
Aldesleukin may increase the hypotensive activities of Indenolol.
DB00086
Streptokinase may increase the hypotensive activities of Indenolol.
DB00268
Ropinirole may increase the hypotensive activities of Indenolol.
DB00295
Morphine may increase the hypotensive activities of Indenolol.
DB00296
Ropivacaine may increase the hypotensive activities of Indenolol.
DB00323
Tolcapone may increase the hypotensive activities of Indenolol.
DB00413
Pramipexole may increase the hypotensive activities of Indenolol.
DB00435
Nitric Oxide may increase the hypotensive activities of Indenolol.
DB00486
Nabilone may increase the hypotensive activities of Indenolol.
DB00631
Clofarabine may increase the hypotensive activities of Indenolol.
DB00681
Amphotericin B may increase the hypotensive activities of Indenolol.
DB00755
Tretinoin may increase the hypotensive activities of Indenolol.
DB00872
Conivaptan may increase the hypotensive activities of Indenolol.
DB00883
Isosorbide dinitrate may increase the hypotensive activities of Indenolol.
DB00887
Bumetanide may increase the hypotensive activities of Indenolol.
DB00903
Etacrynic acid may increase the hypotensive activities of Indenolol.
DB01002
Levobupivacaine may increase the hypotensive activities of Indenolol.
DB01041
Thalidomide may increase the hypotensive activities of Indenolol.
DB01144
Diclofenamide may increase the hypotensive activities of Indenolol.
DB01229
Paclitaxel may increase the hypotensive activities of Indenolol.
DB01235
Levodopa may increase the hypotensive activities of Indenolol.
DB01282
Carbetocin may increase the hypotensive activities of Indenolol.
DB01612
Amyl Nitrite may increase the hypotensive activities of Indenolol.
DB04899
Nesiritide may increase the hypotensive activities of Indenolol.
DB09077
Dinutuximab may increase the hypotensive activities of Indenolol.
DB09112
Nitrous acid may increase the hypotensive activities of Indenolol.
DB09286
Pipamperone may increase the hypotensive activities of Indenolol.
DB09292
Sacubitril may increase the hypotensive activities of Indenolol.
DB00703
Methazolamide may increase the hypotensive activities of Indenolol.
DB01238
The risk or severity of hypotension can be increased when Aripiprazole is combined with Indenolol.
DB14185
The risk or severity of hypotension can be increased when Aripiprazole lauroxil is combined with Indenolol.
DB00373
The risk or severity of adverse effects can be increased when Timolol is combined with Indenolol.
DB00612
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Indenolol.
DB00575
The risk or severity of hypotension can be increased when Clonidine is combined with Indenolol.
DB00656
The risk or severity of QTc prolongation can be increased when Trazodone is combined with Indenolol.
DB00040
The therapeutic efficacy of Indenolol can be decreased when used in combination with Glucagon.
DB00414
The therapeutic efficacy of Acetohexamide can be increased when used in combination with Indenolol.
DB00672
The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Indenolol.
DB00839
The therapeutic efficacy of Tolazamide can be increased when used in combination with Indenolol.
DB01016
The therapeutic efficacy of Glyburide can be increased when used in combination with Indenolol.
DB01067
The therapeutic efficacy of Glipizide can be increased when used in combination with Indenolol.
DB01120
The therapeutic efficacy of Gliclazide can be increased when used in combination with Indenolol.
DB01124
The therapeutic efficacy of Tolbutamide can be increased when used in combination with Indenolol.
DB01251
The therapeutic efficacy of Gliquidone can be increased when used in combination with Indenolol.
DB01289
The therapeutic efficacy of Glisoxepide can be increased when used in combination with Indenolol.
DB08962
The therapeutic efficacy of Glibornuride can be increased when used in combination with Indenolol.
DB13406
The therapeutic efficacy of Carbutamide can be increased when used in combination with Indenolol.
DB13675
The therapeutic efficacy of Metahexamide can be increased when used in combination with Indenolol.
DB01015
The therapeutic efficacy of Indenolol can be increased when used in combination with Sulfamethoxazole.
DB01268
The therapeutic efficacy of Indenolol can be increased when used in combination with Sunitinib.
DB00263
The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Indenolol.
DB00738
The therapeutic efficacy of Pentamidine can be increased when used in combination with Indenolol.
DB00834
The therapeutic efficacy of Mifepristone can be increased when used in combination with Indenolol.
DB08907
The therapeutic efficacy of Indenolol can be increased when used in combination with Canagliflozin.
DB01200
The therapeutic efficacy of Bromocriptine can be increased when used in combination with Indenolol.
DB06292
The therapeutic efficacy of Indenolol can be increased when used in combination with Dapagliflozin.
DB09038
The therapeutic efficacy of Indenolol can be increased when used in combination with Empagliflozin.
DB00030
The therapeutic efficacy of Insulin human can be increased when used in combination with Indenolol.
DB00046
The therapeutic efficacy of Insulin lispro can be increased when used in combination with Indenolol.
DB00047
The therapeutic efficacy of Insulin glargine can be increased when used in combination with Indenolol.
DB00071
The therapeutic efficacy of Insulin pork can be increased when used in combination with Indenolol.
DB01306
The therapeutic efficacy of Insulin aspart can be increased when used in combination with Indenolol.
DB01307
The therapeutic efficacy of Insulin detemir can be increased when used in combination with Indenolol.
DB01309
The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Indenolol.
DB05115
The therapeutic efficacy of NN344 can be increased when used in combination with Indenolol.
DB09456
The therapeutic efficacy of Insulin beef can be increased when used in combination with Indenolol.
DB09564
The therapeutic efficacy of Insulin degludec can be increased when used in combination with Indenolol.
DB11567
The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Indenolol.
DB11568
The therapeutic efficacy of Insulin tregopil can be increased when used in combination with Indenolol.
DB00412
The therapeutic efficacy of Indenolol can be increased when used in combination with Rosiglitazone.
DB00731
The therapeutic efficacy of Indenolol can be increased when used in combination with Nateglinide.
DB00914
The therapeutic efficacy of Indenolol can be increased when used in combination with Phenformin.
DB06203
The therapeutic efficacy of Indenolol can be increased when used in combination with Alogliptin.
DB00197
The therapeutic efficacy of Troglitazone can be increased when used in combination with Indenolol.
DB00284
The therapeutic efficacy of Acarbose can be increased when used in combination with Indenolol.
DB00331
The therapeutic efficacy of Metformin can be increased when used in combination with Indenolol.
DB00359
The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Indenolol.
DB00491
The therapeutic efficacy of Miglitol can be increased when used in combination with Indenolol.
DB00912
The therapeutic efficacy of Repaglinide can be increased when used in combination with Indenolol.
DB01132
The therapeutic efficacy of Pioglitazone can be increased when used in combination with Indenolol.
DB01252
The therapeutic efficacy of Mitiglinide can be increased when used in combination with Indenolol.
DB01261
The therapeutic efficacy of Sitagliptin can be increased when used in combination with Indenolol.
DB01276
The therapeutic efficacy of Exenatide can be increased when used in combination with Indenolol.
DB01277
The therapeutic efficacy of Mecasermin can be increased when used in combination with Indenolol.
DB01278
The therapeutic efficacy of Pramlintide can be increased when used in combination with Indenolol.
DB01382
The therapeutic efficacy of Glymidine can be increased when used in combination with Indenolol.
DB01700
The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Indenolol.
DB04830
The therapeutic efficacy of Buformin can be increased when used in combination with Indenolol.
DB04876
The therapeutic efficacy of Vildagliptin can be increased when used in combination with Indenolol.
DB04878
The therapeutic efficacy of Voglibose can be increased when used in combination with Indenolol.
DB05819
The therapeutic efficacy of NBI-6024 can be increased when used in combination with Indenolol.
DB06011
The therapeutic efficacy of AMG-222 can be increased when used in combination with Indenolol.
DB06127
The therapeutic efficacy of Bisegliptin can be increased when used in combination with Indenolol.
DB06335
The therapeutic efficacy of Saxagliptin can be increased when used in combination with Indenolol.
DB06655
The therapeutic efficacy of Liraglutide can be increased when used in combination with Indenolol.
DB08382
The therapeutic efficacy of Gosogliptin can be increased when used in combination with Indenolol.
DB08882
The therapeutic efficacy of Linagliptin can be increased when used in combination with Indenolol.
DB09022
The therapeutic efficacy of Benfluorex can be increased when used in combination with Indenolol.
DB09043
The therapeutic efficacy of Albiglutide can be increased when used in combination with Indenolol.
DB09045
The therapeutic efficacy of Dulaglutide can be increased when used in combination with Indenolol.
DB09198
The therapeutic efficacy of Lobeglitazone can be increased when used in combination with Indenolol.
DB09199
The therapeutic efficacy of Netoglitazone can be increased when used in combination with Indenolol.
DB09200
The therapeutic efficacy of Rivoglitazone can be increased when used in combination with Indenolol.
DB09201
The therapeutic efficacy of Ciglitazone can be increased when used in combination with Indenolol.
DB09265
The therapeutic efficacy of Lixisenatide can be increased when used in combination with Indenolol.
DB11698
The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Indenolol.
DB11723
The therapeutic efficacy of Dutogliptin can be increased when used in combination with Indenolol.
DB11780
The therapeutic efficacy of Allicin can be increased when used in combination with Indenolol.
DB11824
The therapeutic efficacy of Tofogliflozin can be increased when used in combination with Indenolol.
DB11827
The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Indenolol.
DB11898
The therapeutic efficacy of 2,4-thiazolidinedione can be increased when used in combination with Indenolol.
DB11950
The therapeutic efficacy of Teneligliptin can be increased when used in combination with Indenolol.
DB11992
The therapeutic efficacy of Omarigliptin can be increased when used in combination with Indenolol.
DB12268
The therapeutic efficacy of Carmegliptin can be increased when used in combination with Indenolol.
DB12412
The therapeutic efficacy of Gemigliptin can be increased when used in combination with Indenolol.
DB12417
The therapeutic efficacy of Anagliptin can be increased when used in combination with Indenolol.
DB12625
The therapeutic efficacy of Evogliptin can be increased when used in combination with Indenolol.
DB12713
The therapeutic efficacy of Sotagliflozin can be increased when used in combination with Indenolol.
DB12781
The therapeutic efficacy of Balaglitazone can be increased when used in combination with Indenolol.
DB12935
The therapeutic efficacy of Remogliflozin etabonate can be increased when used in combination with Indenolol.
DB13446
The therapeutic efficacy of Guar gum can be increased when used in combination with Indenolol.
DB13928
The therapeutic efficacy of Semaglutide can be increased when used in combination with Indenolol.
DB14027
The therapeutic efficacy of Taspoglutide can be increased when used in combination with Indenolol.
DB14035
The therapeutic efficacy of Englitazone can be increased when used in combination with Indenolol.
DB15171
The therapeutic efficacy of Tirzepatide can be increased when used in combination with Indenolol.
DB15217
The therapeutic efficacy of Gastric inhibitory polypeptide can be increased when used in combination with Indenolol.
DB11986
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Entrectinib.
DB11642
Indenolol may increase the QTc-prolonging activities of Pitolisant.
DB12825
Lefamulin may increase the QTc-prolonging activities of Indenolol.
DB00763
The excretion of Indenolol can be decreased when combined with Methimazole.
DB01175
The serum concentration of Escitalopram can be increased when it is combined with Indenolol.
DB01224
Indenolol may increase the hypotensive activities of Quetiapine.
DB11732
Lasmiditan may increase the bradycardic activities of Indenolol.
DB15066
The serum concentration of Indenolol can be increased when it is combined with Givosiran.
DB00661
The risk or severity of adverse effects can be increased when Indenolol is combined with Verapamil.
DB00243
The serum concentration of Indenolol can be increased when it is combined with Ranolazine.
DB00557
The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Indenolol.
DB01020
Isosorbide mononitrate may increase the vasodilatory activities of Indenolol.
DB00246
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Ziprasidone.
DB00606
The therapeutic efficacy of Indenolol can be increased when used in combination with Cyclothiazide.
DB01021
The therapeutic efficacy of Indenolol can be increased when used in combination with Trichlormethiazide.
DB01324
The therapeutic efficacy of Indenolol can be increased when used in combination with Polythiazide.
DB13532
The therapeutic efficacy of Cyclopenthiazide can be increased when used in combination with Indenolol.
DB00999
The therapeutic efficacy of Indenolol can be increased when used in combination with Hydrochlorothiazide.
DB00232
The therapeutic efficacy of Indenolol can be increased when used in combination with Methyclothiazide.
DB00436
The therapeutic efficacy of Indenolol can be increased when used in combination with Bendroflumethiazide.
DB00774
The therapeutic efficacy of Indenolol can be increased when used in combination with Hydroflumethiazide.
DB00880
The therapeutic efficacy of Indenolol can be increased when used in combination with Chlorothiazide.
DB00562
The therapeutic efficacy of Indenolol can be increased when used in combination with Benzthiazide.
DB13430
The therapeutic efficacy of Indenolol can be increased when used in combination with Mebutizide.
DB00502
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Haloperidol.
DB00472
The serum concentration of Fluoxetine can be increased when it is combined with Indenolol.
DB00808
The therapeutic efficacy of Indenolol can be increased when used in combination with Indapamide.
DB00104
The serum concentration of the active metabolites of Indenolol can be increased when Indenolol is used in combination with Octreotide.

序列

实验性质

Melting Point
147-148
U.S. Patent 4,045,482.

外部标识符

resource：PubChem Compound
identifier：71955
resource：PubChem Substance
identifier：310264917
resource：KEGG Drug
identifier：D08078
resource：ChemSpider
identifier：64962
resource：Wikipedia
identifier：Indenolol
resource：ChEMBL
identifier：CHEMBL153585

外部链接

路径

目标

酶

BE0002363Cytochrome P450 2D6HumanssubstrateA3633327836712Iwaki M, Niwa T, Bandoh S, Itoh M, Hirose H, Kawase A, Komura H: Application of substrate depletion assay to evaluation of CYP isoforms responsible for stereoselective metabolism of carvedilol. Drug Metab Pharmacokinet. 2016 Dec;31(6):425-432. doi: 10.1016/j.dmpk.2016.08.007. Epub 2016 Sep 2.A1615514732961Brodde OE, Kroemer HK: Drug-drug interactions of beta-adrenoceptor blockers. Arzneimittelforschung. 2003;53(12):814-22.A3633417125412Sternieri E, Coccia CP, Pinetti D, Guerzoni S, Ferrari A: Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments. Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):981-1007. doi: 10.1517/17425255.2.6.981 .noCytochrome P450 2D6Steroid hydroxylase activityResponsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants.CYP2D622q13.1Endoplasmic reticulum membrane7.2655768.9422HumansHUGO Gene Nomenclature Committee (HGNC)HGNC:2625GenAtlasCYP2D6GenBank Gene DatabaseM20403GenBank Protein Database181350Guide to Pharmacology1329UniProtKBP10635UniProt AccessionCP2D6_HUMAN1.14.14.1Cholesterol 25-hydroxylaseCYP2DL1CYPIID6Cytochrome P450-DB1Debrisoquine 4-hydroxylase>lcl|BSEQ0004641|Cytochrome P450 2D6 MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQ LRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVF LARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDK AVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKV LRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVA DLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVI HEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHF LDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGV FAFLVSPSPYELCAVPR>lcl|BSEQ0019275|Cytochrome P450 2D6 (CYP2D6) ATGGGGCTAGAAGCACTGGTGCCCCTGGCCGTGATAGTGGCCATCTTCCTGCTCCTGGTG GACCTGATGCACCGGCGCCAACGCTGGGCTGCACGCTACCCACCAGGCCCCCTGCCACTG CCCGGGCTGGGCAACCTGCTGCATGTGGACTTCCAGAACACACCATACTGCTTCGACCAG TTGCGGCGCCGCTTCGGGGACGTGTTCAGCCTGCAGCTGGCCTGGACGCCGGTGGTCGTG CTCAATGGGCTGGCGGCCGTGCGCGAGGCGCTGGTGACCCACGGCGAGGACACCGCCGAC CGCCCGCCTGTGCCCATCACCCAGATCCTGGGTTTCGGGCCGCGTTCCCAAGGGGTGTTC CTGGCGCGCTATGGGCCCGCGTGGCGCGAGCAGAGGCGCTTCTCCGTGTCCACCTTGCGC AACTTGGGCCTGGGCAAGAAGTCGCTGGAGCAGTGGGTGACCGAGGAGGCCGCCTGCCTT TGTGCCGCCTTCGCCAACCACTCCGGACGCCCCTTTCGCCCCAACGGTCTCTTGGACAAA GCCGTGAGCAACGTGATCGCCTCCCTCACCTGCGGGCGCCGCTTCGAGTACGACGACCCT CGCTTCCTCAGGCTGCTGGACCTAGCTCAGGAGGGACTGAAGGAGGAGTCGGGCTTTCTG CGCGAGGTGCTGAATGCTGTCCCCGTCCTCCTGCATATCCCAGCGCTGGCTGGCAAGGTC CTACGCTTCCAAAAGGCTTTCCTGACCCAGCTGGATGAGCTGCTAACTGAGCACAGGATG ACCTGGGACCCAGCCCAGCCCCCCCGAGACCTGACTGAGGCCTTCCTGGCAGAGATGGAG AAGGCCAAGGGGAACCCTGAGAGCAGCTTCAATGATGAGAACCTGCGCATAGTGGTGGCT GACCTGTTCTCTGCCGGGATGGTGACCACCTCGACCACGCTGGCCTGGGGCCTCCTGCTC ATGATCCTACATCCGGATGTGCAGCGCCGTGTCCAACAGGAGATCGACGACGTGATAGGG CAGGTGCGGCGACCAGAGATGGGTGACCAGGCTCACATGCCCTACACCACTGCCGTGATT CATGAGGTGCAGCGCTTTGGGGACATCGTCCCCCTGGGTGTGACCCATATGACATCCCGT GACATCGAAGTACAGGGCTTCCGCATCCCTAAGGGAACGACACTCATCACCAACCTGTCA TCGGTGCTGAAGGATGAGGCCGTCTGGGAGAAGCCCTTCCGCTTCCACCCCGAACACTTC CTGGATGCCCAGGGCCACTTTGTGAAGCCGGAGGCCTTCCTGCCTTTCTCAGCAGGCCGC CGTGCATGCCTCGGGGAGCCCCTGGCCCGCATGGAGCTCTTCCTCTTCTTCACCTCCCTG CTGCAGCACTTCAGCTTCTCGGTGCCCACTGGACAGCCCCGGCCCAGCCACCATGGTGTC TTTGCTTTCCTGGTGAGCCCATCCCCCTATGAGCTTTGTGCTGTGCCCCGCTAGPF00067p450componentcytoplasmcomponentendoplasmic reticulumcomponentendoplasmic reticulum membranecomponentmitochondrionfunctionarachidonic acid epoxygenase activityfunctionaromatase activityfunctiondrug bindingfunctionheme bindingfunctioniron ion bindingfunctionmonooxygenase activityfunctionoxidoreductase activityfunctionoxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenfunctionoxygen bindingfunctionsteroid hydroxylase activityprocessalkaloid catabolic processprocessalkaloid metabolic processprocessarachidonic acid metabolic processprocesscoumarin metabolic processprocessdrug catabolic processprocessdrug metabolic processprocessexogenous drug catabolic processprocessheterocycle metabolic processprocessisoquinoline alkaloid metabolic processprocessmonoterpenoid metabolic processprocessnegative regulation of bindingprocessnegative regulation of cellular organofluorine metabolic processprocessoxidation-reduction processprocessoxidative demethylationprocesssmall molecule metabolic processprocesssteroid metabolic processprocessxenobiotic metabolic process

载体

运输工具

药物反应

效应

不良反应